16(3): 421-446, Jul./Set. 2006 Natural products inhibitors ... · 422 Natural products inhibitors...
-
Upload
truongcong -
Category
Documents
-
view
216 -
download
0
Transcript of 16(3): 421-446, Jul./Set. 2006 Natural products inhibitors ... · 422 Natural products inhibitors...
421
Revi
são
ISSN 0102-695X
Received 10/24/05. Accepted 04/22/06
* E-mail: [email protected] and [email protected], Tel./Fax + 55-83-32167511
Revista Brasileira de FarmacognosiaBrazilian Journal of Pharmacognosy16(3): 421-446, Jul./Set. 2006
Natural products inhibitors of the angiotensin converting enzyme (ACE). A review between 1980 - 2000
José M. Barbosa-Filho*, Valeska K.M. Martins, Luiza A. Rabelo, Marcelo D. Moura, Marcelo S. Silva, Emidio V.L. Cunha, Maria F.V. Souza, Reinaldo N. Almeida, Isac A. Medeiros*
Laboratório de Tecnologia Farmacêutica “Prof. Delby Fernandes de Medeiros”, Universidade Federal da Paraíba, Caixa Postal 5009, 58051-970, João Pessoa, PB, Brazil
RESUMO: “Produtos naturais inibidores da enzima conversora de angiotensina (ECA). Uma revisão entre 1980 - 2000”. A inibição da Enzima Conversora da Angiotensina (ECA) é um alvo terapêutico moderno e efi caz no tratamento da hipertensão arterial. Na cascata enzimática que envolve o sistema renina-angiotensina, a ECA promove a remoção dos aminoácidos histidil-leucina da angiotensina I para formar o octapeptídio angiotensina II, a qual é fi siologicamente ativa em diversos sistemas, e considerado como um dos mais potentes vasoconstrictores endógenos conhecido. Portanto, uma racionalidade no tratamento da hipertensão seria administrar drogas ou compostos de origem natural que inibam seletivamente a ECA. O presente estudo constitui uma revisão da literatura sobre plantas e moléculas de origem natural com potencial anti-hipertensivo, baseado na inibição in vitro da ECA. A revisão referencia 321 plantas, partes usadas, tipo de extrato e se é ativo ou não. Inclui ainda o nome de 158 compostos isolados de plantas superiores, esponjas e algas marinhas, fungos e venenos de cobra. Alguns aspectos de pesquisa recente com produtos naturais direcionados à produção de drogas anti-hipertensivas também são discutidos. Nesta revisão 148 referências foram consultadas.
Unitermos: Enzima conversora da angiotensina, efeito anti hipertensivo, agentes hipotensivos.
ABSTRACT: Inhibition of Angiotensin Converting Enzyme (ACE) is a modern therapeutic target in the treatment of hypertension. Within the enzyme cascade of the renin-angiotensin system, ACE removes histidyl-leucine from angiotensin I to form the physiologically active octapeptide angiotensin II, one of the most potent known vasoconstrictors. Therefore, a rationale for treating hypertension would be to administer drugs or natural compounds which selectively inhibit ACE. The present work constitutes a review of the literature of plants and chemically defi ned molecules from natural sources with in vitro anti-hypertensive potential based on the inhibition of ACE. The review refers to 321 plants, the parts utilized, type of extract and whether they are active or not. It includes also the names of 158 compounds isolated from higher plants, marine sponges and algae, fungi and snake venom. Some aspects of recent research with natural products directed to produce anti-hypertensive drugs are discussed. In this review, 148 references were cited.
Keywords: Angiotensin converting enzyme, anti-hypertensive effect, hipotensive agents.
INTRODUCTION
The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure defi nes hypertension as systolic blood pressure (SBP) of 140 mm Hg or greater, diastolic blood pressure (DBP) of 90 mm Hg or greater, or taking anti-hypertensive medication. The objective of identifying and treating high blood pressure is to reduce the risk of cardiovascular disease and associated morbidity and mortality. To that end, it is useful to provide a classifi cation of adult blood pressure for the purpose of identifying high-risk individuals and to provide guidelines for treatment. The positive relationship between SBP and DBP and cardiovascular risk has long been recognized.
This relationship is strong, continuous, graded, consistent, independent, predictive, and etiologically signifi cant for those with and without coronary heart disease (Stamler, 1991, Flack et al., 1995). Therefore, although classifi cation of adult blood pressure is somewhat arbitrary, it is useful to clinicians who must make treatment decisions based on a verifi cation of factors including the actual level of blood pressure. Hypertension detection begins with proper blood pressure measurements. Repeated blood pressure measurements will determine whether initial elevations persist and require prompt attention or have returned to normal. According to the National Heart, Lung and Blood Institute (1997), heart disease and stroke remain the fi rst and third leading causes of death, respectively, in the United States and impose an enormous fi nancial and
422
Natural products inhibitors of the angiotensin converting enzyme (ACE). A review between 1980 - 2000
Rev. Bras. Farmacogn.Braz J. Pharmacogn.
16(3):jul/set. 2006
social burden on Americans. In particular, the continued high prevalence of hypertension and hypertension-related complications of stroke, heart failure, and end-stage renal disease in the southeastern United States makes these diseases a public health concern for all who reside in this region, particularly African Americans (Hall et al., 1997). Approximately 50 million adult Americans have hypertension and are still unaware that they have high blood pressure (Burt et al., 1995). In addition, most persons with hypertension have additional risk factors for cardiovascular disease (Furster; Pearson, 1996). Thus, prevention and treatment of hypertension and target organ disease remain important public health challenges that must be addressed as we enter the new millennium. There are different way to treat the problem related to arterial hypertension. Treatment leading to lower levels may be useful, particularly to prevent stroke (Du et al., 1997), to preserve renal function (Lazarus et al., 1997) and to prevent or slow heart failure progression (Krumholz et al., 1997, Neaton et al., 1993). The goal may be achieved by lifestyle modifi cation, alone or with pharmacological treatment.
Non-Pharmacological treatment of arterial hypertension
The main objective of hypertensive treatment is to reduce the high morbidity and mortality. As well as reducing the pressure, an important objective of treatment is to control other cardiovascular risk factors. Lifestyle modifi cations offer the potential for preventing hypertension, have been shown to be effective in lowering blood pressure, and can reduce other cardiovascular risk factors at little cost and with minimal risk (Appel et al., 1997). Even when lifestyle modifi cations alone are not adequate in controlling hypertension, they may reduce the number and dosage of anti-hypertensive medications needed to manage the condition (Neaton et al., 1993, Singer et al., 1995).
Pharmacological treatment of arterial hypertension
Reducing blood pressure with drugs clearly decreases cardiovascular morbidity and mortality. Protection has been demonstrated for stroke, coronary events, heart failure, progression of renal disease,
progression to more severe hypertension, and all-cause mortality (Psaty et al., 1997, Moser; Hebert, 1996). Actually, there are a lot of alternatives available to treat arterial hypertension, both in schemes of monotherapy and/or combined therapy. The effi cacy, security and effects of the different drugs are fundamental criteria to be considered in choosing the anti-hypertensive treatment scheme for each patient. In Table 1 the conventional pharmacological anti-hypertensive medications are presented, further details see references.
Mechanism of anti-hypertensive effect based on the inhibition of the angiotensin converting enzyme (ACE)
The renin-angiotensin-aldosterone system plays a pivotal role in the maintenance of vascular tone vis à vis peripheral resistance. Renin produced from the juxtaglomerular apparatus of the kindney, splits angiotensinogen to produce the inactive decapeptide angiotensin I. The latter is then converted to the powerful octapeptide vasoconstrictor, angiotensin II by the action of angiotensin converting enzyme (ACE). Angiotensin II also stimulates the synthesis and release of aldosterone from the adrenal cortex, which increases blood pressure by promoting sodium retention (and thereby water retention) in the distal tubules (Ahnfelt-Ronne, 1991). Research suggests that angiotensin II stimulates the production of superoxide anion and hydrogen peroxide in the polymorphonuclear leucocytes, which inactivates the vasodilatory compounds endothelial derived vascular relaxing factor (nitric oxide – NO) and prostacyclin (PGI2) (Kumar; Das, 1993). ACE also inactivates the vasodilating nonapeptide bradykinin, which theoretically contributes to the hypertensive effects of ACE activity (Ahnfelt-Ronne, 1991) (Figure 1). Therefore, a good rationale for treating hypertension would be to administer drugs or natural compounds which selectively inhibit ACE. Such selective inhibitors would be capable of decreasing blood pressure and producing natriuresis and diuresis.
In a previous paper this research group has reviewed crude plant extracts and chemically defi ned molecules with potential antitumor activity for mammary (Moura et al., 2001), cervical (Moura et al., 2002) and
Main lifestyle modifi cations for hypertension prevention and management.
Main Lifestyle Modifications - Lose weight if overweight. - Limit alcohol intake - Increase aerobic physical activity - Reduce sodium intake to no more than 100 mmol per day - Maintain adequate intake of dietary calcium and magnesium for general health - Stop smoking - Reduce intake of dietary saturated fat and cholesterol for overall cardiovascular health.
423
José M. Barbosa-Filho, Valeska K.M. Martins, Luiza A. Rabelo, et al.
Rev. Bras. Farmacogn.Braz J. Pharmacogn.16(3):jul/set. 2006
ovarian neoplasias (Silva et al., 2003), as inhibitors of HMG CoA reductase (Gonçalves et al., 2000), central analgesic activity (Almeida et al., 2001), employed in prevention of osteoporosis (Pereira et al., 2002), for the treatment of Parkinson’s disease (Morais, 2003), with antileishmanial (Rocha et al., 2005), hypoglycemic (Barbosa-Filho et al., 2005), antiinfl ammatory activity (Falcão et al., 2005, Barbosa-Filho et al., 2006a) and inhibitors of the enzyme acetylcholinesterase (Barbosa-Filho et al., 2006b).
In this work we present such natural products, in other words, plant extracts, semi purifi ed fractions, chemically defi ned molecules isolated from plants and
metabolites from fungi that act specifi cally inhibiting the angiotensin converting enzyme (ACE), which is one of the most powerful known vasoconstrictors.
MATERIAL AND METHODS
The keyword for this revision was ACE (Angiotensin Converting Enzyme). We made a data search in the Chemical Abstracts, Biological Abstracts and the NAPRALERT (trademark, NAtural PRoducts ALERT) database at the Illinois University, Chicago. The specialized magazines referenced were than searched.
Drugs References Diuretics Kaplan, 1996 Beta-blockers Heintzen; Strauer, 1994 Alpha1-blockers Grimm, 1989; Lasagna, 2000 Alpha2-adrenoceptor agonists Wallin; Frisk-Holmberg, 1981 Calcium channel-blockers Wenzel et al., 2000; Zannad, 2000 Angiotensin II receptor antagonists Burnier; Maillard, 2001; Chung, 1999 Inhibitors of the angiotensin converting enzyme (ACE)
Waeber, 1998; Gustafsson et al., 1998
Table 1. Conventional anti-hypertensive medication
Asp-Arg-Val-Tyr-Lle-His-Pro-Phe-His-Leu - Val-Lle-His-R
angiotensinogen
renin
Asp-Arg-Val-Tyr-Lle-His-Pro-Phe - His-Leu
10 11
angiotensin I
Asp-Arg-Val--Tyr-Lle-His-Pro-Phe
angiotensin II
Vascular smooth
muscle contraction
Aldosteron
secretion
Increased
peripheralresistance
Increased
extracellularfluid volume
HYPERTENSION
ACE
bradykinin
Arg-Pro--Pro-Gly-Phe-Ser-Pro - Phe-Arg
Inactive kinins
vasodilation,
natriuresis
prostaglandins
R = remainder of protein
Figure 1. The suggested hypertensive mechanism of angiotensin. Adapted from Hansen et al., 1995 and Hansen et al., 1996a.
424
Natural products inhibitors of the angiotensin converting enzyme (ACE). A review between 1980 - 2000
Rev. Bras. Farmacogn.Braz J. Pharmacogn.
16(3):jul/set. 2006
RESULTS AND DISCUSSION
Plants which inhibit the angiotensin converting enzyme
Screening for anti-hypertensive effects in traditional medicines has been performed over many years and several animal models have been used (Villar et al., 1986). In western medicine, drug development has become increasingly more mechanistic in focus with the aim of excluding unwanted side-effects. The rationale behind this approach is to identify a molecular target (receptor or enzyme) which has an essential role in the regulation of the disease and then search for ligands, substrates or inhibitors of the target. In the treatment of hypertension, inhibition of the angiotensin converting enzyme (ACE) is established as a modern therapeutic principle. Elbl and Wagner (1991) introduced an in vitro assay for the detection of ACE inhibitors in plant extracts. This method is based on the ACE-catalyzed cleavage of the chromophore-fl uorophore labelled substrate, dansyltriglycine, into dansylglycine, which is quantitatively measured by HPLC (high performance liquid chromatography). By using this technique, a number of plant species have been found to be active (Elbl; Wagner, 1991). Williams et al. (1997) using another bioassay, but also involving ACE inhibition, verifi ed that the leaves and stems of Euphorbia hirta inhibited the activity of angiotensin converting enzyme by 90% and 50% at 500 μg and 150 μg respectively using enzyme linked immunosorbent assay (ELISA). The data are presented in Table 2. The study also revealed that the most active ACE inhibitory compounds were present in the polar and very polar fractions of the medium. The results of the literature survey are presented in Table 3, which lists the effects on angiotensin converting enzyme of 321 plant extracts. The plants are arranged in alphabetical order. Each entry gives the following information in sequence: botanical name, family, part used, type of extract or fraction, whether active or not and reference.
From these studies, is appears to be the possibe, using biomonitored phytochemical methods, to fi nd out new substances potentially active, which may prove important for the development of new substances inhibitors of the angiotensin converting enzyme.
Chemically defi ned molecules inhibitors of the angiotensin converting enzymes
Synthetic drugs such as captopril (Ondetti et al., 1977) or teprotide (Ferreira, 1965), a nonapeptide isolated from the venom of Bothrops jararacussu with established ACE inhibiting activity are used as fi rst line drugs in both secondary and primary hypertension. The rising cost of these and other imported anti-hypertensive drugs stimulates the evaluation of new products as a source of cheaper agents. Several classes of ACE inhibitory compounds were isolated from plants, for example, fl avonoids (Wagner et al., 1991; Wagner; Elbl, 1992; Hansen et al., 1996b), xanthones (Chen et al., 1992), secoiridoids (Hansen et al., 1996a). For a comprehensive review of these compounds, see Hansen (1995). The results of the literature are presented in Table 4, which lists the effects on angiotensin converting enzyme of 158 chemically defi ned molecules. The compounds are arranged in alphabetical order. Each entry gives the following information in sequence: chemical name, class, whether active or not and reference.
CONCLUSION
This revision focussed initially on the search for information about natural product inhibitors of the angiotensin converting enzyme (ACE). From the literature searched, 321 species of plants and 158 natural substances which inhibit ACE were identifed. These natural products may become important for human clinical treatments.
ACKNOWLEDGEMENTS
The authors express their sincere thanks to the College of Pharmacy, The University of Illinois at Chicago, Chicago, Illinois 60612-7231, U.S.A., for
Extract and dose Mean percentage inhibition of ACE Crude methanol 150 μg 500 μg
55.4 ± 0.02 90.3 ± 0.50
Fraction at 150 μg Petroleum ether (non-polar compounds) Chloroform (medium polar) Methanol (polar) Water (very polar)
18.2 ± 2.5 43.7 ± 4.5 48.6 ± 0.9 45.4 ± 1.8
Table 2. Percentage inhibition of angiotensin converting enzyme (ACE) activity by Euphorbia hirta extracts at doses of 500 μg and 150 μg
425
José M. Barbosa-Filho, Valeska K.M. Martins, Luiza A. Rabelo, et al.
Rev. Bras. Farmacogn.Braz J. Pharmacogn.16(3):jul/set. 2006
helping with the computer aided NAPRALERT search of angiotensin-converting enzyme and CNPq/CAPES - Brazil for fi nancial support.
REFERENCES
Ahnfelt-Ronne I 1991. Enzyme inhibitors as drugs. In: Krogsgaard-Larsen P and Bundgaard H (Eds.). A textbook of drug design and development. Switzerland: Harvood Academic Publishers, 302-307.
Almeida RN, Navarro DS, Barbosa-Filho JM 2001. Plants with central analgesic activity Phytomedicine 8: 310-322.
Ando T, Okada S, Uchida I, Hemmi K, Nishikawa M, Tsurumi Y, Fujie A, Yoshida K, Okuhara M 1987. A novel angiotensin converting enzyme inhibitor produced by a fungus, Doratomyces putredinis. J Antibiot 40: 468-475.
Aoyagi T, Wada T, Kojima F, Nagai M, Harada S, Hachisu M, Murata S, Umezawa H 1986. Inhibitors of aminopeptidase B. Suppress the development of hypertension in spontaneously hypertensive rats. Chem Pharz Bull 34: 4852-4854.
Appel LJ, Moore TJ, Obarzanek E 1997. For the DASH Collaborative Research Group. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 336: 1117-1124.
Arisawa M, Nimura M, Ikeda A, Hayashi T, Morita N, Momose Y, Takeda R, Nakanishi S 1986. Biologically active macrocyclic diterpenoids from chinese drug “Fang Feng Cao” I. Isolation and structure. Planta Med 52: 38-41.
Arisawa M, Morinaga Y, Nishi Y, Ueno H, Suzuki S, Hayashi T, Shimizu M, Yoshizaki M, Morita N, Berganza LH 1989). Chemical and pharmaceutical studies on medicinal plants in Paraguay constitueints of angiotensin converting enzyme inhibitory fraction from cocu, Allophylus edulis Radlk. Shoyakugaku Zasshi 43: 78-90.
Ball D, Elliott ME, Hadjokas N, Goodfriend TL, Green MJ 1986. Veratridine, angiotensin receptors and aldosteronogensis in bovine adrenal glomerulosa cells. Clin Exp Hypertens 8: 323-345.
Barbosa-Filho JM, Vasconcelos THC, Alencar AA, Batista LM, Oliveira RAG, Guedes DN, Falcão HS, Moura MD, Diniz MFFM, Modesto-Filho J 2005. Plants and their active constituents from South, Central, and North America with hypoglycemic activity. Rev Bras Farmacogn 15: 392-413.
Barbosa-Filho JM, Piuvezam MR, Moura MD, Silva MS, Lima KVB, Cunha EVL, Fechine IM, Takemura OS 2006a. Anti-infl ammatory activity of alkaloids: A twenty century review. Rev Bras Farmacogn 16: 109-139.
Barbosa-Filho JM, Medeiros KCP, Diniz MFFM, Batista LM, Athayde-Filho PF, Silva MS, Cunha EVL, Almeida JRGS, Quintans-Júnior LJ 2006b. Natural products inhibitors of the enzyme acetylcholinesterase. Rev Bras Farmacogn 16: 258-285
Blaszo G, Gaspar R, Gabor M, Ruve HJ, Rohdewald P 1996. Ace inhibition and hypotensive effect of procyanidins
containing extract from the bark of Pinus pinaster Sol. Pharm Pharmacol Lett 6: 8-11.
Burnier M, Maillard M 2001. The comparative pharmacology of angiotensin II receptor antagonists. Blood Press 10(Suppl 1): 6-11.
Burt VL, Whelton P, Roccella EJ 1995. Prevalence of hypertension in the US adult population: results from the third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 25: 305-313.
Bush K, Henry PR, Souser-Woehleke M, Trejo WH, Slusarchyk DS 1984. Phenacein – An angiotensin-converting enzyme inhibitor produced by a Streptomycete I. Taxonomy, fermentation and biological properties. J Antibiot 37: 1308-1312.
Chen Y, Bean MF, Chambers C, Francis T, Huddleston MJ, Offen P, Westley JW, Carte BK, Timmerman BN 1991. Arrivacins, novel pseudoguaianolide esters with potent angiotensin II binding activity from Ambrosia psilostachya. Tetrahedron 47: 4869-4878.
Chen CH, Lin JY, Lin CN, Hsu SY 1992. Inhibition of angiotensin-I-converting enzyme by tetrahydroxyxanthones isolated from Tripterospermum lanceolatum. J Nat Prod 55: 691-695.
Chen G, Wang X, Yu J, Li L 1996. Effects of gypenosides on hypoxic pulmonary vasoconstriction in healthy men an anesthetized dogs. Zhongguo Bingli Shengli Zazhi 12: 86-90.
Cho YJ, An BJ, Choi C 1993. Isolation and enzyme inhibition of tannins from Korean green tea. Han’Guk Saenghwa Hakhoe Chi 23: 216-223.
Chung O 1999. Angiotensin II receptor blockade and end-organ protection. Am J Hypertens 12(Pt 1-2): 150S-156S.
Crawford MH, Weber MA 1995. Cardiology clinics of North America. Washington: W.B. Saunders, 473-599.
Du X, Cruickshank K, McNamee R 1997. Case-control study of stroke and the quality of hypertension control in north west England. BMJ 314: 272-276.
Elbl G, Wagner H 1991. A new method for the in vitro screening of inhibitors of angiotensin-converting enzyme (ACE), using the chromophore- and fl uorophore-labelled substrate, dansyltriglycine. Planta Med 57: 137-141.
Falcão HS, Lima IO, Santos VL, Dantas HF, Diniz MFFM, Barbosa-Filho JM, Batista LM 2005. Review of the plants with anti-infl ammatory activity studied in Brazil. Rev Bras Farmacogn 15: 381-391.
Ferreira LAF, Henriques OB, Lebrun I, Batista MBC, Prezoto BC, Andreoni ASS, Zelnik R, Habernehl G 1992. A new bradykin-potentiating peptide (peptide P), isolated from the venom of Bothrops jararacussu (Jararacucu Tapete, Urutu Dourado). Toxicon 30: 33-40.
Ferreira SH 1965. A bradykinin-potentiating factor (BPF) present in the venom of Bothrops jararacussu. Brit J Pharmacol 24: 163-169.
Flack JM, Neaton J, Grimm RJr 1995. Multiple Risk Factor Intervention Trial Research Group. Blood pressure and mortality among men with prior myocardial infarction. Circulation 92: 2437-2445.
Fujimoto M, Mihara SI, Nakajima S, Ueda M, Nakamura M,
426
Natural products inhibitors of the angiotensin converting enzyme (ACE). A review between 1980 - 2000
Rev. Bras. Farmacogn.Braz J. Pharmacogn.
16(3):jul/set. 2006
Sakurai KS 1992. A novel non-peptide endothelin antagonist isolated from bayberry, Myrica cerifera. Febs Lett 305: 41-44.
Fuster V, Pearson TA 1996. 27th Bethesda Conference: Matching the intensity of risk factor management with the hazard for coronary disease events, September 14-15, 1995. J Am Coll Cardiol 27: 957-1047.
Gonçalves MCR, Moura LSA, Rabelo LA, Barbosa-Filho JM, Cruz HMM, Cruz J 2000. Produtos naturais inibidores da enzima HMG CoA redutase. Rev Bras Farm 81: 63-71.
Grimm RHJr 1989 Alpha 1-antagonists in the treatment of hypertension. Hypertension 13(Suppl 1): 131-136.
Gustafsson F, Kobe L, Torp-Pedersen C, Hildebrandt P 1998. Infl uence of a history of arterial hypertension and pretreatment blood pressure on the effect of angiotensin converting enzyme inhibition after acute myocardial infarction. Trandolapril Cardiac Evaluation Study. J Hypertens 16(Suppl 1): S65-S70.
Hall WD, Ferrario CM, Moore MA 1997. Hypertension-related morbidity and mortality in the southeastern United States. Am J Med Sci 313: 195-206.
Ham MS, Kims S, Hong JS, Lee JH, Chung EK, Park YS, Lee HY 1996. Screening and comparation of active substances of Angelica gigas Nakai produced in Kangwon and Angelica acutiloba Kitagawa produced in Japan. Sanop Misaengmul Hakhoe Chi 24: 624-629.
Han GQ, Pan JX, Li CL, Tu F 1991. The screening of Chinese traditional drugs by biological assay and the isolation of some active components. Int J Chin Med 16: 1-17.
Hansen K 1995. In vitro screening for the detection of angiotensin converting enzyme (ACE) inhibitors in selected medicinal plants and identifi cation of the active principles. Copenhagen, 116p. [Ph.D. Thesis – The Royal Danish School of Pharmacy, Copenhagen].
Hansen K, Nyman U, Smitt UW, Adsersen A, Gudiksen L, Rajasekharan S, Pushpangadan P 1995. In vitro screening of traditional medicines for anti-hypetrtensive effect based on inhibition of the angiotensin converting enzyme (ACE). J Ethnopharmacol 48: 43-51.
Hansen K, Adsersen A, Christensen SB, Jensen SR, Nyman U, Smitt UW 1996a. Isolation of an angiotensin converting enzyme (ACE) inhibitor from Olea europaea and Olea lancea. Phytomedicine 319-325.
Hansen K, Nyman U, Smitt UW, Adsersen A, Christensen SB, Schwartner C, Wagner H 1996b. Angiotensin converting enzyme (ACE) inhibitory fl avonoids from Erythroxylum laurifolium. Phytomedicine 313-317.
Harris GH, Hoogsteen K, Silverman KC, Raghoobar SL, Bills GF, Lingham RB, Smith JL, Dougherty HW, Cascales C, Pelaez F 1993. Isolation and structure determination of pycnidione, a novel bistropolone stromelysin inhibitor from a Phoma sp. Tetrahedron 49: 2139-2144.
Hashimoto M, Hayashi K, Murai M, Fujii T, Nishikawa M, Kiyoto S, Okuhara M, Kohsaka M, Imanaka H
1992. A novel tachykinin antagonist isolated from Streptomyces violaceusniger NO. 9326II. Biological and pharmacological properties of WS932. A tetrahydro-WS9329A (FK224). J Antibiot 45: 1064-1070.
Heintzen MP, Strauer BE 1994. Peripheral vascular effects of beta-blockers. Eur Heart J 15(Suppl C): 2-7.
Hensens OD, Zink D, Williamson JM, Lotti VJ, Chang RSL, Goetz MA 1991. Variecolin, a sesterterpenoid of novel skeleton from Aspergillus variecolor MF138. J Org Chem 56: 3399-3403.
Higashi Y, Oshima T, Ono N, Hiraga H, Yoshimura M, Watanabe M, Matsuura H, Kambe M, Kajiyama G 1995. Intravenous administration of L-arginine inhibts angiotensin-converting enzyme in humans. J Clin Endocrinol Metab 80: 2198-2202.
Ikemizu S, Konishi H, Hataya C, Kishimoto M 1995. Preparation of angiotensin-converting enzyme inhibitor from mushroom grown of soybean skin. Patent-Japan Kokai Tokkyo Koho-07, 267, 975, 6PP.
Inokuchi JI, Okabe H, Yamauchi T, Nagamatsu A 1984. Inhibitors of angiotensin converting enzyme in crude drugs I. Chem Pharm Bull 32: 3615-3619.
Inokuchi JI, Okabe H, Yamauchi T, Nagamatsu A, Nonakada GI, Nishioka I 1985. Inhibitors of angiotensin converting enzyme in crude drugs II. Chem Pharm Bull 33: 264-269.
Inokuchi JI, Okabe H, Yamauchi T, Nagamatsu A, Nonaka GI, Nishioka I 1996a. Inhibitor of angiotensin converting enzyme. Life Sci 38: 1375-1382.
Inokuchi JI, Okabe H, Yamauchi T, Nagamatsu A, Nonaka GI, Nishioka I 1996b. Antihypertensive substance in seeds in Areca catechu L. Life Sci 38: 1375-1382.
Ishida K, Matsuda H, Murakami M 1998. Four new microginins, linear peptides from the cyanobacterium Microcystis aeruginosa. Tetrahedron 54: 13475-13484.
Izumitani Y, Yahara S, Nohara T 1990. Novel acyclic diterpene glycosides, capsianoisdes A-F and I-V, from Capsicum plants (Solanaceous studies. XIV). Chem Pharm Bull 38: 1299-1307.
Jonader M, Bastide J, Bastide P, Biko V, Carnat A, Lamaison JL 1989. Enzyme inhibiting activites in vitro and in vivo angiopropective activity of Viburnum opulus L. Pharm Acta Helv 64: 94-96.
Kameda K, Takeku T, Okuda H, Kimura Y, Okuda T, Hatano T, Agata I, Arichi S 1987. Inhibitory effects of various fl avanoids isolated from leaves of persimmon on angiotensin-conveting enzyme activity. J Nat Prod 50: 680-683.
Kanetoshi A, Hayashi T, Anetal M, Kaneshima H, Otani M, Minoshima H, Uchivama T, Hatakevama Y, Iida O 1993. Study on the inhibitory effect of Angelicae radix on angiotensin I converting enzyme (ACE) activity as a measure for its optium preparation. Hakkaidoritsu Elsei Kenkyoshoho 43: 1-5.
Kaplan NM 1996. Diuretics: cornerstone of antihypertensive therapy. Am J Cardiol 77: 3B-5B.
Kase H, Kaneko M, Yamada K 1987. A novel inhibitor of angiotensin I converting enzyme produced by Micromonospora halophytica subsp. exilisia I. Fermentation, isolation and biological properties. J Antibiot 40: 450-454.
Kido Y, Hamakado T, Yoshida T, Anno M, Motoki Y, Wakamiya
427
José M. Barbosa-Filho, Valeska K.M. Martins, Luiza A. Rabelo, et al.
Rev. Bras. Farmacogn.Braz J. Pharmacogn.16(3):jul/set. 2006
T, Shiba T 1983. Isolation and characterization of ancovenin, a new inhibitor of angiostensin I converting enzyme, produced by Actinomycetes. J Antibiot 36: 1293-1299.
Kido Y, Hamakado T, Anno M, Miyagawa E, Motoki Y, Wakamiya T, Shiba T 1984. Isolation and characterizacion of 15B2, a new phosphorus containing inhibitor of angiotensin I converting enzyme produced by Actinomadura sp. J Antibiot 37: 965-969.
Kido Y, Hamakado T, Abu M, Miyagawa E, Motoki Y 1985. Angiotensi-converting enzyme inhibitor 15B2 from Actinomycetes. Patent-Japan Kokai Tokkyo Koho-60, 145, 091, 6PP.
Killday KB, Longley R, McCarthy JP, Pomponi SA., Wright AE, Neale RF, Sills MA. Sesquiterpene-derived metabolites from the deep water marine sponge Poecillastra sollasi. J Nat Prod 56: 500-507.
Kimoto K, Kuroda Y, Saito Y, Yamamoto J, Murakami T, Aoyagi Y 1998. Purifi cation and identifi cation of angiotensin I-converting enzyme inhibitor from Morokheiya (Corchorus olitorius). Food Sci Technol Int 4: 223-226.
Kinoshita E, Yamakoshi J, Kikuchi M 1993. Purifi cation and identifi cation of an angiotensin I-coverting enzyme inhibitor from soy sauce. Biosci Biotech Biochem 57: 1107-1110.
Komori Y, Sugihara H 1990. Characterization of a new inhibitor for angiotensin converting enzyme from the venom of vipera Aspis aspis. Int J Biochem 22: 767-771.
Koyama F, Nakamura Y 1993. Antihypertensives and healthy foods containing tripeptide. Patent-Japan Kokai Tokkyo Koho-05, 97, 798, 6PP.
Krassnigg F, Placzek R, Engl R, Frick J, Schill WB 1984. Inhibition mechanism of trifl uoperazine and gossypol on human sperm motility. Contraceptive Delivery Systems 5: 15-16.
Krumholz HM, Parent EM, Tu N 1997. Readmission after hospitalization for congestive heart failure among medicare benefi ciaries. Arch Intern Med 157: 99-104.
Kumar KV, Das UN 1993. Are free radicals involved in the pathobiology of human essential hypertension?. Free Radical Res Commun 19: 59-66.
Lafranconi WM, Huxtable RJ 1983. Changes in angiotensin-converting enzyme activity in lungs damaged by the pyrrolizidine alkaloid monocrotaline. Thorax 38: 307-309.
Lam YKT, Williams-Jr DL, Sigmund JM, Sanchez M, Genilloud O, Kong YL, Stevens-Miles S, Huang L, Garrity GM 1992. Cochinmicins, novel and potent cyclodepsipeptide endothelin antagonist from a Microbispora sp. I. Production, isolation, and characterization. J Antibiot 45: 1709-1716.
Lasagna L 2000. Diuretics vs alpha-blockers for treatment of hypertension: lessons from ALLHAT. Antihypertensive and lipid-lowering treatment to prevent heart attack trial. JAMA 283: 2013-2014.
Lazarus JM, Bourgoignie JJ, Buckalew VM 1997. For the modifi cation of diet in renal disease study group. Achievement and safety of a low blood pressure goal in chronic renal disease. Hypertension 29: 641-650.
Lee HS, Oh WK, Choi HC, Lee JW, Kang DO, Park CS, Mheen TI, Ahn JS 1998. Inhibition of angiotensin II receptor binding by quinolone alkaloids from Evodia rutaecarpa. Phytother Res 12: 212-214.
Lee SD, Hwang WK, Okuda H 1996. Effect of acidic polysaccharide of Korean ginseng on lipolytic action of toxiohormone-L and on activity of angiotensin-converting enzyme. Korean J Ginseng Sci 20: 248-255.
Leem JY, Yook CS 1990. Studies on the chemical components and angiotensin coverting enzyme inhitory activity of Korean Acanthopanax divaricatus seem. Korean J Pharmacogn 21: 250-252.
Lin JY, Chen TS, Chen CS 1994. Flavonoids as nonpeptide angiotensin-converting enzyme inhibitors for hypertension treatment. Patent-Japan Kokai Tokkyo Koho-06, 135, 830, 16PP.
Maeda I, Kato T, Tani A, Aoyagi H, Kihara H, Ohno M 1993. Characterization of peptides isolated from Trimeresurus fl avoviridis and Trimeresurus okinavensis venoms. Bull Chem Soc Japan 66: 1509-1511.
Maruyama S, Miyoshi S, Tanaka H 1989. Angiotensin I-converting enzyme inhibitors derived from Ficus carica. Agr Biol Chem 53: 2763-2767.
Maruyama S, Tanaka H, Maeda H, Mitsuyoshi S, Kaneko T, Yoshizawa Y, Fukui F 1990. Isolation of oligopeptides from sap and fruits of a fi g tree as antihypertensive agents. Patent-Japan Kokai Tokkyo Koho-02, 282, 394, 9PP.
Melzig MF, Pieper S, Siems WE, Heder G, Bottger A, Liberra K, Lindequist U 1996. Screening of selected basidiomycetes of inhitory activity on neutral endopeptidase (NEP) and angiotensin-converting enzyme (ACE). Pharmazie 51: 501-503.
Meunier MT, Villie F, Jonadet M, Bastide J, Bastide P 1987. Inhibitors of angiotensin converting enzyme by fl avanolic compounds: in vitro and in vivo studies. Planta Med 53: 12-15.
Mikami Y, Suzuki T 1983. Novel microbial inhibitors of angiotensin-converting enzyme, aspergillomarasmines A and B. Agr Biol Chem 47: 2693-2695.
Mitane SY, Suguire T, Miwa Y, Yamaguchi K, Kyuki K 1996. Effect of tea-leaf saponin on blood pressure of spontaneously hypertensive rats. Yakugaku Zasshi 116: 388-395.
Miyata S, Hashimoto M, Fujie K, Nishikawa M, Kiyoto S, Okuhara M, Kohsaka M 1992. New endothelin receptor antagonists isolated from Streptomcyes sp. NO. 7338. II. Biological characterization and pharmacological characterization of WS-7338 B. J Antibiot 45: 83-87.
Molteni A, Ward WF, Ts’Ao CH, Port CD, Solliday NH 1984. Monocrotaline-induced pulmonary endothelial dysfunction in rats. Proc Soc Exp Biol Med 176: 88-94.
Momose Y, Nimura M, Arisawa M, Hayashi T, Takeda R, Nakanashi S 1994. Hypotensive activity of ovatodiolides isolated from a Chinese crude drug “Fang Feng Cao”. Phytother Res 8: 482-484.
Morais LCSL, Barbosa-Filho JM, Almeida RN 2003. Plants and bioactives compounds for the treatment of
428
Natural products inhibitors of the angiotensin converting enzyme (ACE). A review between 1980 - 2000
Rev. Bras. Farmacogn.Braz J. Pharmacogn.
16(3):jul/set. 2006
Parkinson’s desease. Arquivo de Fitomedicina 1: 127-132.
Morishita Y, Sano T, Ando K, Saitoh Y, Kase H, Yamada K, Matsuda Y 1991. Microbial polysaccharide HS-142-1, competitively and selectively inhibits and binding to its guanylyl cyclase-containing receptor. Biochem Biophys Res Commun 176: 994-997.
Morita H, Yoshida N, Takeya K, Itokawa H, Shirota O 1996. Confi guration and conformational analyses of a cyclic octapeptide, Lyciumin A, from Lycium chinese Mill. Tetrahedron 52: 2795-2802.
Morota T, Sasaki H, Chin M, Sato T, Katayma N, Fukuyama K, Mitsuhashi H 1987. Studies on the crude drug containing the angiotensin-I converting enzyme inhibitors on the active principles of Lycium chinense Muller. Shoyakugaku Zasshi 41: 169-173.
Moser M, Hebert PR (1996) Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 27: 1214-1218.
Moura MD, Torres AR, Oliveira RAG, Diniz MFFM, Barbosa-Filho JM 2001. Natural products inhibitors of models of mammary neoplasia. Brit J Phytotherapy 5: 124-145.
Moura MD, Silva JS, Oliveira RAG, Diniz MFFM, Barbosa-Filho JM 2002. Natural products reported as potential inhibitors of uterine cervical neoplasia. Acta Farm Bonaerense 21: 67-74.
Mynderse JS, O’Connor SC, Nakatsukasa WM 1984. Enzyme inhibitors. Patent-Eur-103, 403, 52PP.
Mynderse JS, Samlaska SK, Fukuda DS, Du-Bus RH, Baker PJ 1985. Isolation of A58365A and A58365B, angiotensin converting enzyme inhibitors produced by Streptomyces chromofuscus. J Antibiot 38: 1003-1007.
National Heart, Lung, and Blood Institute 1997. Fact Book Fiscal Year 1996. Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health.
Neaton JD, Grimm RHJr, Prineas RJ 1993. For the Treatment of Mild Hypertension Study Research Group. Final results. JAMA 270: 713-724.
Niitsu K, Ikeya Y, Sato T, Katayama N, Fukuyama K, Chin M, Taguchi H, Mitsuhashi H 1987. Studies on the crude drug containing the angiotensin I converting enzyme inhibitors. (II). On the active principles of Frittilaria verticillata willdenow var. thumbergii Baker. Shoyakugaku Zasshi 41: 174-179.
O’Connor S, Somers P 1985. Methods for the detection and quantitation of angiotensin converting enzyme inhibitors in fermentation broths. J Antibiot 38: 993-996.
Ogino T, Sato S, Sasaki H, Chin M 1986. Isolation and structure determination of 1,3,4-tridehydrofangchinolium hydroxide. Patent-Japan Kokai Tokkyo Koho-62, 294, 684, 5PP.
Ogino T, Sato S, Sasaki H, Chin M 1987a. Angiotensin I converting enzyme inhibiting activity of tetrandrine, fangchinoline and derivatives thereof and pharmaceutical compositions containing them. Patent-Japan Kokai Tokkyo Koho-62, 207, 216, 11PP.
Ogino T, Sato S, Sasaki H, Chin M 1987b. Isolation of
new alkaloids from Stephania tetrandra as antihypertensives. Patent-Japan Kokai Tokkyo Koho-62, 205, 084, 5PP.
Ogino T, Katsuhara T, Sato T, Sasaki H, Okada M, Maruno M 1998. New alkaloids from the root of Stephania tetrandra (Fen-Fang-JI). Heterocycles 48: 311-317.
Oh WK, Kang DO, Park CS, Ahn SC, Ko HR, Kim BY, Mheen TI, Ahn JS, Lee HS 1997. Screening of the angiotensin II antagonists from medicinal plants. Korean J Pharmacogn 28: 26-34.
Okamot Y, Yoshizawa T 1994. Angiotensin-converting enzyme inhibitors and aldose reductase inhibitors containing Passifl ora quadrangularis extracts or vitexin. Patent-Japan Kokai Tokkyo Koho-06, 293, 657, 4PP.
Okamura K, Iwakami S, Matsunaga T 1992 Biological activity of monoterpenes. Toyama-Ken Yakuji Kenkyusho Nenpo 20: 95-101.
Okino T, Matsuda H, Murakami M, Yamaguchi K 1993. Microginin, an angiotensin-converting enzyme inhibitor from the blue-green alga Microcystis aeruginosa. Tetrahedron Lett 34: 501-504.
Olafsson K, Jaroszewski JW, Smitt UW, Nyman U 1997. Isolation of angiotensin converting enzyme (ACE) inhibiting triterpenes from Schinus molle. Planta Med 63: 352-355.
Ondetti MA, Rubin B, Cushman DW 1997. Design of specifi c inhibitiors of angiotensin-converting enzyme new class of orally active antihypertensive agents. Science 196: 441-443.
Packer L, Rimbach G, Virgili F 1999. Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol. Free Radical Biol Med 37: 704-724.
Parnas BL, Durley RC, Rhoden EE, Kilpatrick BF, Makkar N, Thomas KE, Smith WG, Corley DG 1996. Isolation and structure of leukotriene-A-4 hydrolase inhibitor: 8(S)-amino-2(R)-methyl-7-oxononanoic acid produced by Streptomyces. J Nat Prod 59: 962-964.
Pereira JV, Modesto-Filho J, Agra MF, Barbosa-Filho JM 2002. Plant and plant-derived compounds employed in prevention of the osteoporosis. Acta Farm Bonaerense 21: 223-234.
Psaty BM, Smith NL, Siscovick DS 1997. Health outcomes associated with antihypertensive therapies used as fi rst-line agents: a systematic review and meta-analysis. JAMA 277: 739-745.
Rocha LG, Almeida JRGS, Macedo RO, Barbosa-Filho JM 2005. A review of natural products with antileishmanial activity. Phytomedicine 12: 514-535.
Sakurai T, Yamada H, Saito KI, Kano Y 1993. Enzyme inhibitory activities of acetylene and sesquiterpene compounds in Atractylodes rhizome. Biol Pharm Bull 16: 142-145.
Sanz MJ, Terencio MC, Paya M 1993. Pharmacological actions of a new procyanidin polymer from Pistacia lenticus L. Pharmazie 48: 152-153.
Sauru MD, Camporesi DA, Sudakow RL 1995. The antitumor agent, taxol, attenuates contractile activity in rat aortic smooth muscle. Life Sci 56: 157-161.
Scholkens BA, Gehring D, Scholotte V, Weithmann U 1982. Evening primrose oil, a dietary prostaglandin
429
José M. Barbosa-Filho, Valeska K.M. Martins, Luiza A. Rabelo, et al.
Rev. Bras. Farmacogn.Braz J. Pharmacogn.16(3):jul/set. 2006
precursor, diminishes vascular reactivity to renin and angiotensin II in rats. Prostraglandin Leukotrienes Med 8: 273-285.
Sendl A, Elbl G, Steinke B, Redl K, Breu W, Wagner H 1992. Comparative pharmacological investigations of Allium ursinum and Allium sativum. Planta Med 58: 1-7.
Shimizu E, Hayashi A, Takahashi R, Aoyagi Y, Murakami T, Kimoto K 1999. Effects of angiotensin-I converting enzyme inhibitor from Ashitaba (Angelica keiskei) on blood pressure of spontaneously hypertensive rats. J Nutr Sci Vitamol 45: 375-383.
Silva JS, Moura MD, Oliveira RAG, Diniz MFFM, Barbosa-Filho JM 2003. Natural products inhibitors of ovarian neoplasia. Phytomedicine 10: 221-232.
Singer DRJ, Markandu ND, Cappuccio FP, Miller MA, Sagnella GA, Macgregor GA 1995. Reduction of salt intake during converting enzyme inhibitor treatment compared with addition of a thiazide. Hypertension 25: 1042-1044.
Singh PD, Johnson JH 1984. Muraceins-muramyl peptides produced by Nocardia orientalis as angiotensi-converting enzyme inhibitors. II. Isolation and structure determination. J Antibiot 37: 336-343.
Somanadhan B, Smitt UW, George V, Pushpangadan P, Rajasekharan S, Duus JO, Nyman U, Olsen CE, Jaroszewski JW 1998. Angiotensin converting enzyme (ACE) inhitors from Jasminum azoricum and Jasminum granifl orum. Planta Med 64: 246-250.
Stamler J 1991. Blood pressure and high blood pressure: aspects of risk. Hypertension 18(Suppl I): 95-107.
Stevens-Miles S, Goetz MA, Bills GF, Giacobre RA, Tkacz JS, Chang RSL, Mojena M, Martin I, Diez MT, Pelaez F, Hensens OD, Jones T, Burg RW, Kong YL, Huang LY 1996. Discovery of an antiotensin II binding inhibitor from a Cytospora sp. using semi-automated screening procedures. J Antibiot 49: 119-123.
Sutter MC, Wang YX 1993. Recent cardiovascular drugs from Chinese medicinal plants. Cardiovasc Res 27: 1891-1901.
Takai S, Sakaguchi M, Jin D, Baba K, Miyazaki M 1999. Effects of daphnodorin A, daphnodorin B and daphnodorin C on human chymase-dependent angiotensin II formation. Life Sci 64: 1889-1896.
Takashari T, Sato T, Kaneshima H 1993. Inhibitor of angiotensin converting enzyme from Acathopanax senticosus. Hokkaidoritsu Eisei Kenkyusho Ho 43: 63-64.
The 1988 Report of the Joint National Commitee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Int Med 148: 1023-1038.
Tsi D, Tan BKH 1997. Cardiovascular pharmacology of 3-N-butylphthalide in spontaneously hypertensive rats. Phytother Res 11: 576-582.
Uchida S, Ikari N, Ohta H, Niwa M, Nonaka GI, Nishioka I, Ozaki M 1987. Inhibitory effects of condensed tannins on angiotensin converting enzyme. Jap J Pharmacol 43: 242-246.
Ueno H, Horie S, Nishi Y, Shogawa H, Kawasaki M, Suzuki S, Hayashi T, Arisawa M, Shimizu M, Yoshizaki M, Morita N 1988. Chemical and pharmaceutical studies on medicinal plants in Paraguay. Geraniin,
an angiotensin-converting enzyme inhibitor from “Paraparai mi”, Phyllanthus niruri. J Nat Prod 51: 357-359.
Villar A, Paya M, Terencio MC 1986. Plants with antihypertensive action. Fitoterapia 57: 131-145.
Waeber B 1998. The place of ACE inhibition in the modern therapeutic era: beyond blood pressure control. Introduction. J Cardiovasc Pharmacol,32(Suppl 2): 5-6.
Wagner H, Elbl G, Lotter H, Guinea M 1991. Evaluation of natural products as inhibitors of angiotensin I-converting enzyme (ACE). Pharm Pharmacol Lett 1: 15-18.
Wagner H, Elbl G 1992. ACE-inhibitory procyanidins from Lespedeza capitata. Planta Med 58: 297-298.
Wakamiya T, Ueki Y, Shiba T, Kido Y, Motoki Y 1985. The structure of ancovenin, a new peptide inhibitor of angiotensin I converting enzyme. Tetrahedron Lett 26: 665-668.
Wallin BG, Frisk-Holmberg M 1981. The antihypertensive mechanism of clonidine in man. Evidence against a generalized reduction of sympathetic activity. Hypertension 3: 340-346.
Wenzel RR, Bruck H, Noll G, Schafers RF, Daul AE, Philipp T 2000. Antihypertensive drugs and the sympathetic nervous system. J Cardiovasc Pharmacol 35(7 Suppl. 4): S43-S52.
Williams LAD, Gossell-Williams M, Barton EN, Fleischhacker R 1997. Angiotensin converting enzyme inhibiting and anti-dipsogenic activities of Euphorbia hirta extracts. Phytother Res 11: 401-402.
Yahara M, Nohara T, Irino N, Okueda H, Izumitani Y 1990. Isolation of diterpenoid glycosides, capsianosides, from Capsicum as antihypertensive agents. Patent-Japan Kokai Tokkyo Koho-02, 138, 289, 14PP.
Yahara S, Shigeyama C, Nohara T, Okuda H, Wakamatsu K, Yasuhara T 1989. Structures of anti-ACE and renin peptides from Lycii radicis cortex. Tetrahedron Lett 30: 6041-6042.
Yahara S, Shigeyama C, Ura T, Wakamatsu K, Yasuhara T, Nohara T 1993. Ciclic peptides, acyclic diterpene glycosides and other compounds from Lycium chinense Mill. Chem Pharm Bull 41: 703-709.
Yamadaki M, Shimoyama A 1992. Angiotensin-converting enzyme I inhibitor extraction from the Eucommia ulmoides leaves. Patent-Japan Kokai Tokkya Koho-04, 368, 336, 5PP.
Yamahara J, Kobayashi G, Iwamoto M, Matsuda H, Fujimura H 1989. The effect of alismol isolated from Alismatis rhizoma on experimental hypertensive models in rats. Phytother Res 3: 57-60.
Yamato M, Koguchi T, Okachi R, Yamada K, Nakayama K, Kase H, Karasawa A, Shuto K 1986. A novel inhibitor of angiotensin I converting enzyme produced by an Actinomycete K-26. J Antibiot 39: 44-52.
Yeung BKS, Nakao Y, Kinnel RB, Carney JR, Yoshida WY, Scheuer PJ, Kelly-Gorges M 1996. The kapakahines, cyclic peptides from the marine sponge Cribrochalina olemda. J Org Chem 61: 7168-7183.
Zannad F 2000. The potential advantages of a modern antihypertensive therapy in the elderly. J Cardiovasc Pharmacol 35(3 Suppl. 1): S19-23.
430
Natural products inhibitors of the angiotensin converting enzyme (ACE). A review between 1980 - 2000
Rev. Bras. Farmacogn.Braz J. Pharmacogn.
16(3):jul/set. 2006
Tab
le 3
. Pla
nt e
xtra
cts s
umm
ary
show
ing
inhi
bitio
n of
ang
iote
nsin
con
verti
ng e
nzym
e Sp
ecie
s Fa
mily
Pa
rt us
ed
Extra
ct
Act
ivity
R
efer
ence
Ab
rus c
anto
nien
sis
Faba
ceae
D
ried
aeria
l H
2O
Inac
tive
Han
et a
l., 1
991
Abut
ilon
indi
cum
M
alva
ceae
R
oot
Roo
t R
oot
Ace
tone
Et
OH
(95%
) H
2O
Wea
k In
activ
e W
eak
Han
sen,
199
5 H
anse
n, 1
995
Han
sen,
199
5 Ac
hyra
nthe
s asp
era
Am
aran
thac
eae
Aer
ial p
arts
A
eria
l par
ts
Aer
ial p
arts
Ace
tone
Et
OH
(95%
) H
2O
Wea
k A
ctiv
e W
eak
Han
sen,
199
5 H
anse
n, 1
995
Han
sen,
199
5 Ac
hyra
nthe
s bid
enta
ta
Am
aran
thac
eae
Drie
d ro
ot
MeO
H-H
2O (1
:1)
Inac
tive
Inok
uchi
et a
l., 1
984
Achy
rant
hes j
apon
ica
Am
aran
thac
eae
Roo
t M
eOH
In
activ
e O
h et
al.,
199
7 Ac
hyra
nthe
s rub
rofu
sca
Am
aran
thac
eae
Aer
ial p
arts
A
eria
l par
ts
Ace
tone
Et
OH
(95%
) W
eak
Wea
k H
anse
n, 1
995
Han
sen,
199
5 Ac
onitu
m k
orea
num
R
anun
cula
ceae
Tu
ber
MeO
H
Inac
tive
Oh
et a
l., 1
997
Acon
itum
locz
nanu
m
Ran
uncu
lace
ae
Roo
t M
eOH
In
activ
e O
h et
al.,
199
7 Ac
orus
gra
min
eus
Ara
ceae
R
hizo
me
Drie
d rh
izom
e M
eOH
H
2O
Inac
tive
Wea
k O
h et
al.,
199
7 H
an, 1
991
Actin
idia
arg
uta
Act
inid
acea
e Fr
uit
MeO
H
Inac
tive
Oh
et a
l., 1
997
Actin
oste
mm
a lo
batu
m
Cuc
urbi
tace
ae
Drie
d en
tire
plan
t M
eOH
-H2O
(1:1
) A
ctiv
e In
okuc
hi e
t al.,
198
4 Ag
rim
onia
pilo
sa
Ros
acea
e A
eria
l par
ts
MeO
H
Inac
tive
Oh
et a
l., 1
997
Ajug
a de
cum
bens
La
mia
ceae
D
ried
entir
e pl
ant
MeO
H-H
2O (1
:1)
Inac
tive
Inok
uchi
et a
l., 1
984
Akeb
ia sp
. La
rdiz
abal
acea
e D
ried
stem
M
eOH
-H2O
(1:1
) In
activ
e In
okuc
hi e
t al.,
198
4 Al
bizia
julib
rissin
Fa
bace
ae
Bar
k D
ried
bark
M
eOH
H
2O
Inac
tive
Equi
voca
l O
h et
al.,
199
7 H
an, 1
991
Alism
a or
ient
ale
Alis
mat
acea
e D
ried
rhiz
ome
Drie
d rh
izom
e R
hizo
me
MeO
H-H
2O (1
:1)
H2O
M
eOH
Inac
tiva
Act
ive
Inac
tive
Inok
uchi
et a
l., 1
984
Han
, 199
1 O
h et
al.,
199
7 Al
lium
sativ
um
Lilia
ceae
Fr
esh
bulb
Ly
ophi
lized
In
activ
e Se
ndl e
t al.,
199
2 Al
lium
urs
inum
Li
liace
ae
Fres
h bu
lb
Fres
h le
af
Lyop
hiliz
ed
Lyop
hiliz
ed
Inac
tive
Act
ive
Send
l et a
l., 1
992
Send
l et a
l., 1
992
Allo
phyl
us e
dulis
Sa
pind
acea
e B
ranc
hes
Bra
nche
s B
ranc
hes
Bra
nche
s B
ranc
hes
Hex
ane
CH
Cl 3
BuO
H
EtO
H (7
0%)
H2O
Inac
tive
Inac
tive
Act
ive
Act
ive
Inac
tive
Aris
awa
et a
l., 1
989
Aris
awa
et a
l., 1
989
Aris
awa
et a
l., 1
989
Aris
awa
et a
l., 1
989
Aris
awa
et a
l., 1
989
Anem
arrh
ena
asph
odel
oide
s Li
liace
ae
Riz
hom
e M
eOH
In
activ
e O
h et
al.,
199
7 An
gelic
a ac
utilo
ba
Api
acea
e D
ried
root
D
ried
root
Et
OH
(95%
) D
ecoc
tion
Act
ive
Act
ive
Ham
et a
l., 1
996
Kan
etos
hi e
t al.,
199
3 An
gelic
a gi
gas
Api
acea
e D
ried
root
R
oot
EtO
H (9
5%)
MeO
H
Act
ive
Wea
k H
am e
t al.,
199
6 O
h et
al.,
199
7 An
gelic
a ke
iske
i A
piac
eae
Drie
d le
af
EtO
H (8
0%)
Act
ive
Shim
izu
et a
l., 1
999
431
José M. Barbosa-Filho, Valeska K.M. Martins, Luiza A. Rabelo, et al.
Rev. Bras. Farmacogn.Braz J. Pharmacogn.16(3):jul/set. 2006
Ange
lica
kore
ana
Api
acea
e R
izho
me
MeO
H
Inac
tive
Oh
et a
l., 1
997
Ange
lica
pube
scen
s A
piac
eae
Drie
d ro
ot
MeO
H-H
2O (1
:1)
H2O
In
activ
e W
eak
Inok
uchi
et a
l., 1
984
Han
et a
l., 1
991
Ange
lica
sinen
sis
Api
acea
e
Drie
d ro
ot
H2O
Eq
uivo
cal
Han
et a
l., 1
991
Ange
lica
spec
ies
Api
acea
e D
ried
root
M
eOH
-H2O
(1:1
) In
activ
e In
okuc
hi e
t al.,
198
4 An
gelic
a te
nuiss
ima
Api
acea
e R
izho
me
MeO
H
Inac
tive
Oh
et a
l., 1
997
Arct
ium
lapp
a A
ster
acea
e D
ried
fruit
Drie
d fru
it Se
ed
MeO
H-H
2O (1
:1)
H2O
M
eOH
Inac
tive
Equi
voca
l In
activ
e
Inok
uchi
et a
l., 1
984
Han
et a
l., 1
991
Oh
et a
l., 1
997
Arec
a ca
tech
u A
reca
ceae
D
ried
seed
D
ried
seed
D
ried
seed
Chr
omat
og. f
ract
ion
MeO
H-H
2O (1
:1)
Tann
in fr
actio
n
Act
ive
Act
ive
Act
ive
Inok
uchi
et a
l., 1
984
Inok
uchi
et a
l., 1
984
Inok
uchi
et a
l., 1
996a
Ar
isaem
a am
uren
se
Ara
ceae
R
izho
me
MeO
H
Inac
tive
Oh
et a
l., 1
997
Arisa
ema
cons
angu
ineu
m
Ara
ceae
D
ried
rizho
me
H2O
A
ctiv
e H
an 1
991
Arist
oloc
hia
cont
orta
A
risto
loch
iace
ae
Aer
ial p
arts
M
eOH
In
activ
e O
h et
al.,
199
7 Ar
istol
ochi
a de
bilis
A
risto
loch
iace
ae
Drie
d ro
ot
H2O
A
ctiv
e H
an 1
991
Arist
oloc
hia
man
shur
iens
is A
risto
loch
iace
ae
Drie
d st
em
Stem
St
em
Stem
H2O
A
ceto
ne
EtO
H (9
5%)
H2O
Wea
k A
ctiv
e A
ctiv
e A
ctiv
e
Han
199
1 H
anse
n et
al.,
199
5 H
anse
n et
al.,
199
5 H
anse
n et
al.,
199
5 Ar
istot
elia
chi
lens
is
Elae
ocar
pace
ae
Bar
k Et
OH
(95%
) A
ctiv
e H
anse
n et
al.,
199
5 Ar
tem
isia
apia
ceae
A
ster
acea
e A
eria
l par
ts
MeO
H
Inac
tive
Oh
et a
l., 1
997
Arte
misi
a ca
pilla
ris
Ast
erac
eae
Aer
ial p
arts
D
ried
entir
e M
eOH
M
eOH
-H2O
(1:1
) In
activ
e In
activ
e O
h et
al.,
199
7 In
okuc
hi e
t al.,
198
4 As
arum
het
erot
ropo
ides
A
risto
loch
iace
ae
Drie
d ae
rial
H2O
A
ctiv
e H
an e
t al.,
199
1 As
arum
sieb
oldi
i A
risto
loch
iace
ae
Aer
ial p
arts
D
ried
aeria
l M
eOH
H
2O
Inac
tive
Act
ive
Oh
et a
l., 1
997
Han
et a
l., 1
991
Asar
um sp
. A
risto
loch
iace
ae
Drie
d en
tire
plan
t M
eOH
-H2O
(1:1
) In
activ
e In
okuc
hi e
t al.,
198
4 As
para
gus c
ochi
nche
nens
is Li
liace
ae
Drie
d ro
ot
H2O
In
activ
e H
an e
t al.,
199
1 As
tilbe
chi
nens
is
Saxi
fraga
ceae
A
eria
l par
ts
MeO
H
Inac
tive
Oh
et a
l., 1
997
Astra
galu
s mem
bran
aceu
s Fa
bace
ae
Drie
d ro
ot
MeO
H-H
2O (1
:1)
Inac
tive
Inok
uchi
et a
l., 1
984
Astra
galu
s sin
icus
Fa
bace
ae
Aer
ial p
arts
M
eOH
In
activ
e O
h et
al.,
199
7 At
ract
ylod
es ja
poni
ca
Ast
erac
eae
Rhi
zom
e R
hizo
me
Rhi
zom
e
CH
Cl 3
H2O
M
eOH
Wea
k W
eak
Wea
k
Oh
et a
l., 1
997
Oh
et a
l., 1
997
Oh
et a
l., 1
997
Atra
ctyl
odes
mac
roce
phal
a A
ster
acea
e D
ried
rhiz
ome
H2O
Eq
uivo
cal
Han
et a
l., 1
991
Bela
mca
nda
chin
ensis
Iri
dace
ae
Drie
d rh
izom
e D
ried
root
M
eOH
-H2O
(1:1
) H
2O
Inac
tive
Equi
voca
l In
okuc
hi e
t al.,
198
4 H
an e
t al ,
199
1 Be
ninc
asa
hisp
ida
Cuc
urbi
tace
ae
Seed
M
eOH
W
eak
Oh
et a
l., 1
997
Bisto
rta su
ffulta
Po
lygo
nace
ae
Aer
ial p
arts
M
eOH
In
activ
e O
h et
al.,
199
7 Bo
ehm
eria
niv
ea
Urti
cace
ae
Aer
ial p
arts
M
eOH
In
activ
e O
h et
al.,
199
7
432
Natural products inhibitors of the angiotensin converting enzyme (ACE). A review between 1980 - 2000
Rev. Bras. Farmacogn.Braz J. Pharmacogn.
16(3):jul/set. 2006
Boeh
mer
ia tr
icus
pis
Urti
cace
ae
Aer
ial p
arts
M
eOH
In
activ
e O
het a
l., 1
997
Boer
havi
a di
ffusa
N
ycta
gina
ceae
R
oot
Roo
t R
oot
Ace
tone
Et
OH
(95%
) H
2O
Wea
k W
eak
Act
ive
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Bupl
euru
m fa
lcat
um
Api
acea
e R
oot
Roo
t R
oot
CH
Cl 3
H2O
M
eOH
Wea
k In
activ
e W
eak
Oh
et a
l., 1
997
Oh
et a
l., 1
997
Oh
et a
l., 1
997
Cam
ellia
japo
nica
Th
eace
ae
Flow
ers
MeO
H
Inac
tive
Oh
et a
l., 1
997
Cam
ellia
sine
nsis
Th
eace
ae
Gre
en le
af
Drie
d le
af
Ace
tone
A
ceto
ne
Act
ive
Inac
tive
Cho
et a
l., 1
993
Mita
ne e
t al.,
199
6 Ca
rdio
sper
mum
hal
icac
abum
Sa
pind
acea
e A
eria
l par
ts
Aer
ial p
arts
A
eria
l par
ts
Ace
tone
Et
OH
(95%
) H
2O
Wea
k In
activ
e W
eak
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Card
us c
rispu
s A
ster
acea
e A
eria
l par
ts
MeO
H
Inac
tive
Oh
et a
l., 1
997
Carp
esiu
m a
brot
anoi
des
Ast
erac
eae
Aer
ial p
arts
M
eOH
In
activ
e O
h et
al.,
199
7 Ca
rsel
la b
ursa
-pas
toris
B
rass
icas
eae
Drie
d en
tire
plan
t M
eOH
-H2O
(1:1
) In
activ
e In
okuc
hi e
t al.,
198
4 Ca
ssia
obt
usifo
lia
Faba
ceae
D
ried
seed
H
2O
Inac
tive
Han
et a
l., 1
991
Cass
ia sp
. Fa
bace
ae
Drie
d se
ed
MeO
H-H
2O (1
:1)
Inac
tive
Inok
uchi
et a
l., 1
984
Cayr
atia
japo
nica
V
itace
ae
Aer
ial p
arts
M
eOH
In
activ
e O
h et
al.,
199
7 Ce
lastr
us o
rbic
ulat
us
Cel
astra
ceae
R
oot
MeO
H
Inac
tive
Oh
et a
l., 1
997
Cent
ella
asia
tica
Api
acea
e A
eria
l par
ts
Aer
ial p
arts
A
eria
l par
ts
Ace
tone
Et
OH
(95%
) H
2O
Act
ive
Act
ive
Act
ive
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Cent
iped
a m
inim
a A
ster
acea
e D
ried
aeria
l H
2O
Inac
tive
Han
et a
l., 1
991
Chen
opod
ium
alb
um
Che
nopo
diac
eae
Drie
d en
tire
plan
t M
eOH
-H2O
(1:1
) In
activ
e In
okuc
hi e
t al.,
198
4 Ch
ysan
then
um in
dicu
m
Ast
erac
eae
Flow
ers
MeO
H
Inac
tive
Oh
et a
l., 1
997
Chys
anth
enum
lava
ndul
aefo
lium
A
ster
acea
e D
ried
flow
ers
H2O
A
ctiv
e H
an e
t al.,
199
1 Ci
mic
ifuga
foet
ida
Ran
uncu
lace
ae
Drie
d riz
hom
e M
eOH
-H2O
(1:1
) In
activ
e In
okuc
hi e
t al.,
198
4 Ci
mic
ifuga
her
acle
ifolia
R
anun
cula
ceae
R
hizo
me
MeO
H
Inac
tive
Oh
et a
l., 1
997
Cinn
amom
um c
assi
a
Laur
acea
e B
ark
Drie
d ba
rk
Drie
d tw
ig
MeO
H
Tann
in fr
actio
n H
2O
Inac
tive
Act
ive
Inac
tive
Oh
et a
l., 1
997
Inok
uchi
et a
l., 1
984
H
an e
t al.,
199
1 Ci
nnam
omum
zeyl
anic
um
Laur
acea
e D
ried
bark
D
ried
bark
C
hrom
atog
. fra
ctio
n M
eOH
-H2O
(1:1
) A
ctiv
e A
ctiv
e In
okuc
hi e
t al.,
198
4 In
okuc
hi e
t al.,
198
4 Ci
rsiu
m ja
poni
cum
A
ster
acea
e A
eria
l par
ts
MeO
H
Inac
tive
Oh
et a
l., 1
997
Citru
s aur
antiu
m
Rut
acea
e D
ried
fruit
H2O
In
activ
e H
an e
t al.,
199
1 Ci
trus u
nshi
u R
utac
eae
Fras
s M
eOH
In
activ
e O
h et
al.,
199
7 Cl
emat
is ap
iifol
ia
Ran
uncu
lace
ae
Aer
ial p
arts
M
eOH
In
activ
e O
h et
al.,
199
7 Cl
emat
is ch
inen
sis
Ran
uncu
lace
ae
Drie
d ro
ot
MeO
H-H
2O (1
:1)
Inac
tive
Inok
uchi
et a
l., 1
984
Clem
atis
hera
clei
folia
R
anun
cula
ceae
A
eria
l par
ts
MeO
H
Inac
tive
Oh
et a
l., 1
997
Clem
atis
man
dsch
uric
a R
anun
cula
ceae
R
oot
MeO
H
Inac
tive
Oh
et a
l., 1
997
433
José M. Barbosa-Filho, Valeska K.M. Martins, Luiza A. Rabelo, et al.
Rev. Bras. Farmacogn.Braz J. Pharmacogn.16(3):jul/set. 2006
Cler
oden
drum
tric
hoto
mum
V
erbe
nace
ae
Aer
ial p
arts
M
eOH
W
eak
Oh
et a
l., 1
997
Cnid
ium
offi
cina
le
Api
acea
e R
hizo
me
MeO
H
Inac
tive
Oh
et a
l., 1
997
Cnid
ium
sp.
Api
acea
e D
ried
rhiz
ome
MeO
H-H
2O (1
:1)
Inac
tive
Inok
uchi
.et a
l., 1
984
Coix
lacr
yma-
jobi
Po
acea
e D
ried
seed
H
2O
Equi
voca
l H
an e
t al.,
199
1 Co
llybi
a dr
yoph
ila
Tric
holo
mat
acea
e D
ried
orga
nism
H
2O
Inac
tive
Mel
zig
et a
l., 1
996
Cono
psis
pilo
sula
C
ampa
nula
ceae
D
ried
root
M
eOH
-H2O
(1:1
) In
activ
e In
okuc
hi e
t al.,
198
4 Co
rnus
offi
cina
lis
Cor
nace
ae
Frui
t M
eOH
In
activ
e O
h et
al.,
199
7 Co
rnus
sp.
Cor
nace
ae
Fres
h fru
it M
eOH
-H2O
(1:1
) In
activ
e In
okuc
hi e
t al.,
198
4 Co
ryda
lis te
rnat
a Pa
pave
race
ae
Tube
r M
eOH
In
activ
e O
h et
al.,
199
7 Co
rylu
s het
erop
hyla
B
etul
acea
e A
eria
l par
ts
MeO
H
Inac
tive
Oh
et a
l., 1
997
Crat
aegu
s pin
natif
ida
Ros
acea
e D
ried
fruit
Seed
Fl
ower
s Fl
ower
s Fl
ower
s
H2O
M
eOH
A
ceto
ne
EtO
H (9
5%)
H2O
Act
ive
Inac
tive
Inac
tive
Inac
tive
Wea
k
Han
et a
l., 1
991
Oh
et a
l., 1
997
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Crat
aegu
s sp.
R
osac
eae
Fres
h fru
it M
eOH
-H2O
(1:1
) A
ctiv
e In
okuc
hi e
t al.,
198
4 Cr
emas
tra v
aria
bilis
O
rchi
dace
ae
Tube
r M
eOH
In
activ
e O
h et
al.,
199
7 Cu
pres
sus s
empe
rvir
ens
Cup
ress
acea
e D
ried
fruit
Flav
onoi
d fr
actio
n A
ctiv
e M
euni
er e
t al.,
198
7 Cu
rcul
igo
orch
ioid
es
Hyp
oxid
acea
e D
ried
rizho
me
H2O
In
activ
e H
an e
t al.,
199
1 Cy
athu
la o
ffici
nalis
A
mar
anth
acea
e D
ried
root
H
2O
Wea
k H
an e
t al.,
199
1 Cy
noste
mm
a pe
ntap
hylla
C
ucur
bita
ceae
D
ried
aeria
l In
fusi
on
Act
ive
Che
n et
al.,
199
6 Cy
peru
s rot
undu
s C
yper
acea
e D
ried
rizho
me
H2O
In
activ
e H
an e
t al.,
199
1 D
aeda
leop
sis c
onfra
gosa
Po
lypo
race
ae
Drie
d or
gani
sm
H2O
W
eak
Mel
zig
et a
l., 1
996
Dal
berg
ia o
dorif
era
Fa
bace
ae
Drie
d w
ood
H2O
A
ctiv
e H
an e
t al.,
199
1 D
aphn
e ge
nkwa
Th
ymel
aece
ae
Drie
d flo
wer
s H
2O
Equi
voca
l H
an e
t al.,
199
1 D
endr
obiu
m sp
. O
rchi
dace
ae
Drie
d or
gani
sm
MeO
H-H
2O (1
:1)
Inac
tive
Inok
uchi
et a
l., 1
984
Des
mod
ium
gan
getic
um
Faba
ceae
R
oot
Roo
t R
oot
Ace
tone
Et
OH
(95%
) H
2O
Inac
tive
Act
ive
Act
ive
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Des
mod
ium
styr
acifo
lium
Fa
bace
ae
Leaf
+ S
tem
A
ceto
ne
EtO
H (9
5%)
H2O
Act
ive
Act
ive
Act
ive
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Dia
nthu
s sup
erbu
s C
aryo
phyl
lace
ae
Drie
d se
ed
MeO
H-H
2O (1
:1)
Inac
tive
Inok
uchi
et a
l., 1
984
Dic
hroa
febr
ifuga
Sa
xifra
gace
ae
Aer
ial p
arts
M
eOH
In
activ
e O
h et
al.,
199
7 D
icta
mnu
s das
ycar
pus
Rut
acea
e D
ried
bark
B
lood
H
2O
MeO
H
Inac
tive
Inac
tive
Han
et a
l., 1
991
Oh
et a
l., 1
997
Dio
scor
ea o
ppos
ita
Dio
scor
eace
ae
Drie
d ro
ot
H2O
W
eak
Han
et a
l., 1
991
Dio
spyr
os k
aki
Eben
acea
e D
ried
leaf
C
alix
M
eOH
-H2O
(1:1
) M
eOH
In
activ
e In
activ
e In
okuc
hi e
t al.,
198
4 O
h et
al.,
199
7 D
ipsa
cus a
sper
D
issa
cace
ae
Drie
d ro
ot
H2O
Eq
uivo
cal
Han
et a
l., 1
991
Dry
nari
a fo
rtune
i Po
lypo
diac
eae
Rhy
zom
e H
2O
Equi
voca
l H
an e
t al.,
199
1
434
Natural products inhibitors of the angiotensin converting enzyme (ACE). A review between 1980 - 2000
Rev. Bras. Farmacogn.Braz J. Pharmacogn.
16(3):jul/set. 2006
Echi
nops
setif
er
Ast
erac
eae
Roo
t M
eOH
In
activ
e O
h et
al.,
199
7 El
euth
ecoc
cus d
ivar
icat
us
Ara
liace
ae
Drie
d ste
mba
rk
BuO
H
Act
ive
Leem
199
0 El
euth
ecoc
cus g
raci
listy
lus
Ara
liace
ae
Drie
d ba
rk
Drie
d ro
ot
H2O
H
2O
Wea
k Eq
uivo
cal
Han
et a
l., 1
991
Han
et a
l., 1
991
Eleu
thec
occu
s sen
ticos
us
Ara
liace
ae
Drie
d ste
m
CH
Cl 3
Act
ive
Taka
shar
i et a
l., 1
993
Eleu
thec
occu
s ses
silifl
orus
A
ralia
ceae
B
ark
MeO
H
Inac
tive
Oh
et a
l., 1
997
Elsh
oltzi
a sp
lend
ens
Lam
iace
ae
Drie
d ae
rial p
arts
H2O
W
eak
Han
et a
l., 1
991
Enta
da p
ursa
etha
Fa
bace
ae
Seed
Se
ed
Seed
Ace
tone
Et
OH
(95%
) H
2O
Wea
k A
ctiv
e A
ctiv
e
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Ephe
dra
sinic
a
Ephe
drac
eae
Drie
d ae
rial p
arts
Tann
in fr
actio
n A
ctiv
e In
okuc
hi e
t al.,
198
5 Ep
hedr
a sp
. Ep
hedr
acea
e D
ried
entir
e pl
ant
Drie
d en
tire
plan
t C
hrom
atog
. fra
ctio
n M
eOH
-H2O
(1:1
) A
ctiv
e A
ctiv
e In
okuc
hi e
t al.,
198
4 In
okuc
hi e
t al.,
198
4 Ep
imed
ium
alp
inum
B
erbe
ridac
eae
Drie
d ae
rial p
arts
Ta
nnin
frac
tion
Act
ive
Inok
uchi
et a
l., 1
985
Epim
ediu
m b
revi
corn
um
Ber
berid
acea
e N
ot sp
ecifi
ed
H2O
A
ctiv
e H
an e
t al.,
199
1 Ep
imed
ium
mac
rant
hum
B
erbe
ridac
eae
Drie
d en
tire
plan
t D
ried
entir
e pl
ant
Chr
omat
og. f
ract
ion
MeO
H-H
2O (1
:1)
Act
ive
Act
ive
Inok
uchi
et a
l., 1
984
Inok
uchi
et a
l., 1
984
Equi
setu
m h
yem
ale
Equi
seta
ceae
D
ried
stem
H
2O
Act
ive
Han
et a
l., 1
991
Eryt
hrox
ylum
laur
ifoliu
m
Eryt
hrox
ylac
eae
Drie
d le
af
EtO
H (1
00%
) A
ctiv
e H
anse
n et
al.,
199
6b
Esca
lloni
a m
yrtio
ides
G
ross
ular
iace
ae
Aer
ial p
arts
Et
OH
(96%
) W
eak
Han
sen
et a
l., 1
995
Euco
mm
ia u
lmio
des
Euco
mm
iace
ae
Drie
d ba
rk
Drie
d ba
rk
MeO
H-H
2O (1
:1)
H2O
In
activ
e In
activ
e In
okuc
hi e
t al.,
198
4 H
an e
t al.,
199
1 Eu
odia
offi
cina
lis
Rut
acea
e Fr
uit
Frui
t Fr
uit
CH
Cl 3
H2O
M
eOH
Wea
k In
activ
e W
eak
Oh
et a
l., 1
997
Oh
et a
l., 1
997
Oh
et a
l., 1
997
Euon
ymus
ala
tus
Cel
astra
ceae
B
ark
MeO
H
Inac
tive
Will
iam
s et a
l., 1
997
Eupa
toriu
m fo
rtune
i A
ster
acea
e
Drie
d ae
rial p
arts
H2O
Eq
uivo
cal
Han
et a
l., 1
991
Euph
orbi
a hi
rta
Euph
orbi
acea
e D
ried
leaf
M
eOH
A
ctiv
e W
illia
ms e
t al.,
199
7 Eu
phor
bia
hum
ifusa
Eu
phor
biac
eae
Drie
d ae
rial p
arts
H2O
A
ctiv
e H
an e
t al.,
199
1 Eu
phor
bia
kans
ui
Euph
orbi
acea
e D
ried
aeria
l par
ts D
ried
aeria
l par
ts
Drie
d ae
rial p
arts
CH
Cl 3
H2O
M
eOH
Wea
k In
activ
e W
eak
Oh
et a
l., 1
997
Oh
et a
l., 1
997
Oh
et a
l., 1
997
Euph
oria
long
ana
Sapi
ndac
eae
Drie
d fru
it H
2O
Wea
k H
an e
t al.,
199
1 Fl
amm
ulin
a ve
lutip
es
Tric
holo
mat
acea
e D
ried
orga
nism
H
2O
Wea
k M
elzi
g et
al.,
199
6 Fo
mes
fom
enta
rius
Poly
pora
ceae
D
ried
orga
nism
H
2O
Inac
tive
Mel
zig
et a
l., 1
996
Fom
itops
is pi
nico
la
Poly
pora
ceae
D
ried
orga
nism
H
2O
Inac
tive
Mel
zig
et a
l., 1
996
Fors
ythi
a su
spen
sa
Ole
acea
e D
ried
fruit
H2O
Eq
uivo
cal
Han
et a
l., 1
991
Friti
llaria
sp.
Lilia
ceae
D
ried
bulb
M
eOH
-H2O
(1:1
) A
ctiv
e In
okuc
hi e
t al.,
198
4 Fu
chsi
a m
agel
lani
ca
Ona
grac
eae
Aer
ial p
arts
H
2O
Act
ive
Han
sen
et a
l., 1
995
Gal
ium
ver
um
Rub
iace
ae
Aer
ial p
arts
M
eOH
W
eak
Oh
et a
l., 1
997
Gan
oder
ma
lipsie
nse
Gan
oder
mat
acea
e D
ried
orga
nism
H
2O
Inac
tive
Mel
zig
et a
l., 1
996
435
José M. Barbosa-Filho, Valeska K.M. Martins, Luiza A. Rabelo, et al.
Rev. Bras. Farmacogn.Braz J. Pharmacogn.16(3):jul/set. 2006
Gan
oder
ma
luci
dum
G
anod
erm
atac
eae
Drie
d or
gani
sm
H2O
W
eak
Han
et a
l., 1
991
Gar
deni
a ja
smin
oide
s R
ubia
ceae
D
ried
fruit
Frui
t D
rid fr
uit
MeO
H-H
2O (1
:1)
MeO
H
H2O
Inac
tive
Inac
tive
Equi
voca
l
Inok
uchi
et a
l., 1
984
Oh
et a
l., 1
997
Han
et a
l., 1
991
Gea
stru
m m
elan
ocep
halu
m
Ges
trace
ae
Drie
d or
gani
sm
H2O
In
activ
e M
elzi
g et
al.,
199
6 G
entia
na m
acro
phyl
la
Gen
tiana
ceae
D
ried
root
D
ried
root
M
eOH
-H2O
(1:1
) H
2O
Inac
tive
Equi
voca
l In
okuc
hi e
t al.,
198
4 H
an e
t al.,
199
1 G
entia
na sc
abra
G
entia
nace
ae
Roo
t M
eOH
In
activ
e O
h et
al.,
199
7 G
eran
ium
cor
e-co
re
Ger
ania
ceae
A
eria
l par
ts
H2O
A
ctiv
e H
anse
n et
al.,
199
5 G
eran
ium
wilf
ordi
i G
eran
iace
ae
Drie
d ae
rial p
arts
H
2O
Inac
tive
Han
et a
l., 1
991
Geu
m ja
poni
cum
R
osac
eae
Aer
ial p
arts
M
eOH
In
activ
e O
h et
al.,
199
7 G
lehn
ia li
ttora
lis
Api
acea
e D
ried
root
H
2O
Equi
voca
l H
an e
t al.,
199
1 G
lycy
rrhi
za u
rale
nsis
Fa
bace
ae
Roo
t R
oot
MeO
H
H2O
In
activ
e In
activ
e O
h et
al.,
199
7 H
an e
t al.,
199
1 G
unne
ra ti
ncto
ria
Gun
nera
ceae
Le
af
Leaf
Le
af
BuO
H
EtO
Ac
EtO
H (9
5%)
Act
ive
Act
ive
Act
ive
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Hed
ysar
um p
olyb
otry
s Fa
bace
ae
Drie
d ro
ot
H2O
A
ctiv
e H
an e
t al.,
199
1 H
elia
nthu
s tub
eros
us
Ast
erac
eae
Aer
ila p
arts
M
eOH
In
activ
e O
h et
al.,
199
7 H
eter
obas
idio
n an
nosu
s Po
lypo
race
ae
Drie
d or
gani
sm
H2O
In
activ
e M
elzi
g et
al.,
199
6 H
exac
hlam
ys e
dulis
M
yrta
ceae
Le
af
Leaf
A
ceto
ne-H
2O (1
:1)
EtO
H (9
5%)
Stro
ng
Act
ive
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Hom
alom
ena
occu
lta
Ara
ceae
D
ried
root
H
2O
Equi
voca
l H
an e
t al.,
199
1 H
outtu
ynia
cor
data
Sa
urur
acea
e A
eria
l par
ts
Entir
e pl
ant
Entir
e pl
ant
Entir
e pl
ant
Drie
d ae
rial p
arts
D
ried
entir
e pl
ant
MeO
H
Ace
tone
Et
OH
(95%
) H
2O
H2O
M
eOH
-H2O
(1:1
)
Equi
voca
l A
ctiv
e A
ctiv
e A
ctiv
e Eq
uivo
cal
Inac
tive
Oh
et a
l., 1
997
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Han
et a
l., 1
991
Inok
uchi
et a
l., 1
984
Inon
otus
obl
iqus
H
ymen
ocha
etac
eae
Drie
d or
gani
sm
H2O
In
activ
e M
elzi
g et
al.,
199
6 In
ula
japo
nica
A
ster
acea
e A
eria
l par
ts
Drie
d flo
wer
s M
eOH
H
2O
Inac
tive
Equi
voca
l O
h et
al.,
199
7 H
an e
t al.,
199
1 Ja
smin
un a
zoric
um
Ole
acea
e D
ried
aeria
l par
ts
Drie
d ae
rial p
arts
D
ried
aeria
l par
ts
Drie
d ae
rial p
arts
CH
2Cl 2
Chr
omat
og. f
ract
ion
EtO
Ac
H2O
Act
ive
Act
ive
Act
ive
Act
ive
Som
anad
han
et a
l., 1
998
Som
anad
han
et a
l., 1
998
Som
anad
han
et a
l., 1
998
Som
anad
han
et a
l., 1
998
Junc
us e
ffesu
s Ju
ncac
eae
Tube
r A
eria
l par
ts
MeO
H
MeO
H
Inac
tive
Inac
tive
Oh
et a
l., 1
997
Oh
et a
l., 1
997
Kalo
pana
x pi
ctus
A
ralia
ceae
B
ark
MeO
H
Inac
tive
Oh
et a
l., 1
997
Knox
ia v
aler
iano
ides
R
ubia
ceae
D
ried
root
H
2O
Equi
voca
l H
an e
t al.,
199
1 Ko
elre
uter
ia p
anic
ulat
a Sa
pind
acea
e A
eria
l par
ts
MeO
H
Inac
tive
Oh
et a
l., 1
997
436
Natural products inhibitors of the angiotensin converting enzyme (ACE). A review between 1980 - 2000
Rev. Bras. Farmacogn.Braz J. Pharmacogn.
16(3):jul/set. 2006
Kueh
nero
myc
es m
utab
ilis
Stro
phar
iace
ae
Drie
d or
gani
sm
H2O
In
activ
e M
elzi
g et
al.,
199
6 La
ctar
ius d
eter
rimus
R
ussa
lace
ae
Drie
d en
tire
plan
t H
2O
Inac
tive
Mel
zig
et a
l., 1
996
Leon
urus
sibi
ricus
La
mia
ceae
A
eria
l par
ts
Drie
d en
tire
plan
t M
eOH
M
eOH
-H2O
(1:1
) In
activ
e In
activ
e O
h et
al.,
199
7 In
okuc
hi e
t al.,
198
4 Le
piso
rus t
hunb
ergi
anus
Po
lypo
diac
eae
Aer
ial p
arts
M
eOH
In
activ
e O
h et
al.,
199
7 Le
sped
eza
capi
tata
Fa
bace
ae
Drie
d le
af
Flav
onoi
d fr
actio
n A
ctiv
e W
agne
r, El
bl, 1
992
Liliu
m b
rown
ii Li
liace
ae
Drie
d bu
lb
H2O
Eq
uivo
cal
Han
et a
l., 1
991
Lind
era
stryc
hnifo
lia
Laur
acea
e D
ried
root
H
2O
Wea
k H
an e
t al.,
199
1 Li
riope
pla
typh
yla
Lilia
ceae
Tu
ber
MeO
H
Inac
tive
Oh
et a
l., 1
997
Loni
cera
japo
nica
C
aprif
olia
ceae
Fl
ower
s D
ried
flow
ers
MeO
H
H2O
In
activ
e W
eak
Oh
et a
l., 1
997
Han
et a
l., 1
991
Lora
nthu
s par
asiti
cus
Lora
ntha
ceae
A
eria
l par
ts
Drie
d en
tire
plan
t M
eOH
H
2O
Inac
tive
Inac
tive
Oh
et a
l., 1
997
Han
et a
l., 1
991
Luffa
aeg
yptia
ca
Cuc
urbi
tace
ae
Drie
d se
ed
MeO
H-H
2O (1
:1)
Inac
tive
Inok
uchi
et a
l., 1
984
Lyci
um c
hine
se
Sola
nace
ae
Drie
d fru
it D
ried
leaf
D
ried
root
back
Fr
uit
Drie
d ro
otba
rk
Drie
d ro
otba
rk
MeO
H-H
2O (1
:1)
MeO
H-H
2O (1
:1)
Not
sta
ted
MeO
H
CH
Cl 3
MeO
H-H
2O (1
:1)
Inac
tive
Inac
tive
Act
ive
Inac
tive
Act
ive
Inac
tive
Inok
uchi
et a
l., 1
984
Inok
uchi
et a
l., 1
984
Yah
ara,
et a
l., 1
993
Oh
et a
l., 1
997
Mor
ota
et a
l., 1
987
Inok
uchi
et a
l., 1
984
Lyco
pus c
orea
nus
Lam
iace
ae
Aer
ial p
arts
M
eOH
In
activ
e O
h et
al.,
199
7 Ly
godi
um ja
poni
cum
Sc
hiza
eace
ae
Drie
d ae
rial p
arts
H2O
A
ctiv
e H
an e
t al.,
199
1 Ly
sim
achi
a ba
rysta
chys
Pr
imul
acea
e A
eria
l par
ts
MeO
H
Inac
tive
Oh
et a
l., 1
997
Mac
hilu
s thu
nber
gii
Laur
acea
e B
ark
Bar
k B
ark
CH
Cl 3
H2O
M
eOH
Act
ive
Inac
tive
Act
ive
Oh
et a
l., 1
997
Oh
et a
l., 1
997
Oh
et a
l., 1
997
Mac
role
piot
a rh
acod
es
Lepi
otac
eae
Drie
d or
gani
sm
H2O
W
eak
Mel
zig
et a
l., 1
996
Mag
nolia
den
usat
a M
agno
liace
ae
Flow
ers
MeO
H
Inac
tive
Oh
et a
l., 1
997
Mag
nolia
sp.
Mag
nolia
ceae
D
ried
bark
D
ried
flow
ers
MeO
H-H
2O (1
:1)
MeO
H-H
2O (1
:1)
Inac
tive
Inac
tive
Inok
uchi
et a
l., 1
984
Inok
uchi
et a
l., 1
984
Mah
onia
bea
lei
Ber
berid
acea
e D
ried
leaf
H
2O
Equi
voca
l H
an e
t al.,
199
1 M
alus
bac
cata
R
osac
eae
Aer
ial p
arts
M
eOH
In
activ
e O
h et
al.,
199
7 M
elia
aze
dara
ch
Mel
iace
ae
Frui
t M
eOH
In
activ
e O
h et
al.,
199
7 M
enisp
erm
um d
auric
um
Men
ispe
rmac
eae
Aer
ial p
arts
M
eOH
In
activ
e O
h et
al.,
199
7 M
enth
a ar
vens
is
Lam
iace
ae
Aer
ial p
arts
M
eOH
In
activ
e O
h et
al.,
199
7 M
erip
ilus g
igan
teus
Po
lypo
race
ae
Drie
d or
gani
sm
H2O
In
activ
e M
elzi
g et
al.,
199
6 M
erre
mia
trid
enta
ta
Con
volv
ulac
eae
Aer
ial p
arts
A
eria
l par
ts
Aer
ial p
arts
Ace
tone
Et
OH
(95%
) H
2O
Inac
tive
Act
ive
Act
ive
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Mor
mod
ica
coch
inch
inen
sis
Cuc
urbi
tace
ae
Drie
d se
ed
Seed
M
eOH
-H2O
(1:1
) M
eOH
In
activ
e In
activ
e In
okuc
hi e
t al.,
198
4 O
h et
al.,
199
7
437
José M. Barbosa-Filho, Valeska K.M. Martins, Luiza A. Rabelo, et al.
Rev. Bras. Farmacogn.Braz J. Pharmacogn.16(3):jul/set. 2006
Mor
us a
lba
M
orac
eae
Bar
k D
ried
bark
D
ried
fruit
Drie
d le
af
Drie
d le
af
Drie
d le
af
CH
Cl 3
H2O
H
2O
MeO
H
MeO
H-H
2O (1
:1)
MeO
H-H
2O (1
:1)
Inac
tive
Wea
k Eq
uivo
cal
Wea
k In
activ
e A
ctiv
e
Oh
et a
l., 1
997
Oh
et a
l., 1
997
Han
et a
l., 1
991
Oh
et a
l., 1
997
Inok
uchi
et a
l., 1
984
Inok
uchi
et a
l., 1
984
Myr
istic
a fr
agra
ns
Myr
istic
acea
e Se
ed
MeO
H
Inac
tive
Oh
et a
l., 1
997
Nelu
mbo
nuc
ifera
N
ymph
aeac
eae
Drie
d se
ed
H2O
In
activ
e H
an e
t al.,
199
1 No
topt
eryg
ium
inci
sum
A
piac
eae
Drie
d ro
ot
H2O
W
eak
Han
et a
l., 1
991
Oen
othe
ra b
ienn
is
Ona
grac
eae
Seed
Se
ed o
il A
ctiv
e Sc
holk
ens e
t al.,
198
2 O
phio
pogo
n ja
poni
cus
Lilia
ceae
D
ried
root
H
2O
Equi
voca
l H
an e
t al.,
199
1 O
plop
anax
ela
tus
Ara
liace
ae
Roo
t M
eOH
In
activ
e O
h et
al.,
199
7 Pa
chym
ia h
oele
n Po
lypo
race
ae
Frui
tbod
y M
eOH
In
activ
e O
h et
al.,
199
7 Pa
eoni
a al
biflo
ra
Paeo
niac
eae
Drie
d ro
ot
H2O
A
ctiv
e H
an e
t al.,
199
1 Pa
eoni
a m
outa
n
Paeo
niac
eae
Drie
d ba
rk
Drie
d ba
rk
Drie
d ba
rk
Chr
omat
og. f
ract
ion
MeO
H-H
2O (1
:1)
Tann
in fr
actio
n
Act
ive
Act
ive
Act
ive
Inok
uchi
et a
l., 1
984
Inok
uchi
et a
l., 1
984
Inok
uchi
et a
l., 1
985
Paeo
nia
obov
ata
Paeo
niac
eae
Roo
t M
eOH
In
activ
e O
h et
al.,
199
7 Pa
nax
gins
eng
Ara
liace
ae
Rhi
zom
e +
root
D
ried
root
Po
lysa
ccha
r.fra
ctio
n M
eOH
-H2O
(1:1
) W
eak
Inac
tive
Lee
et a
l., 1
996
Inok
uchi
et a
l., 1
984
Pana
x ps
eudo
gins
eng
Ara
liace
ae
Drie
d ro
ot
H2O
Eq
uivo
cal
Han
et a
l., 1
991
Pass
iflor
a qu
adra
ngul
aris
Pa
ssifl
orac
eae
Drie
d en
tire
plan
t H
2O
Act
ive
Oka
mot
et a
l., 1
994
Patr
inia
scab
iosa
efol
ia
Val
eria
nace
ae
Drie
d ro
ot
H2O
W
eak
Han
et a
l., 1
991
Patr
inia
vill
osa
Val
eria
nace
ae
Roo
t M
eOH
In
activ
e O
h et
al.,
199
7 Pa
xillu
s inv
olut
us
Paxi
llace
ae
Drie
d or
gani
sm
H2O
In
activ
e M
elzi
g et
al.,
199
6 Pe
rilla
frut
esce
ns
Lam
iace
ae
Aer
ial p
arts
A
eria
l par
ts
Aer
ial p
arts
Se
ed
CH
Cl 3
H2O
M
eOH
M
eOH
Wea
k W
eak
Wea
k W
eak
Oh
et a
l., 1
997
Oh
et a
l., 1
997
Oh
et a
l., 1
997
Oh
et a
l., 1
997
Pers
icar
ia se
ntic
osa
Poly
gona
ceae
A
eria
l par
ts
MeO
H
Inac
tive
Oh
et a
l., 1
997
Peuc
edan
um ja
poni
cum
A
piac
eae
Roo
t R
oot
Roo
t
CH
Cl 3
H2O
M
eOH
Inac
tive
Inac
tive
Wea
k
Oh
et a
l., 1
997
Oh
et a
l., 1
997
Oh
et a
l., 1
997
Phae
olus
schw
eini
tzii
Hym
enoc
haet
acea
e D
ried
orga
nism
H
2O
Wea
k M
elzi
g et
al.,
199
6 Ph
ello
dend
ron
amur
ense
R
utac
eae
Bar
k M
eOH
In
activ
e O
h et
al.,
199
7 Ph
lom
is um
bros
a La
mia
ceae
R
oot
MeO
H
Inac
tive
Oh
et a
l., 1
997
Phol
iota
squa
rbos
a St
roph
aria
ceae
D
ried
orga
nism
H
2O
Inac
tive
Mel
zig
et a
l., 1
996
Phry
ma
lept
ossta
chya
Ph
rym
acea
e A
eria
l par
ts
MeO
H
Inac
tive
Oh
et a
l., 1
997
Phyl
lant
hus n
iruri
Euph
orbi
acea
e D
ried
entir
e pl
ant
Chr
omat
og. f
ract
ion
Act
ive
Uen
o, e
t al.,
198
8 Pi
cras
ma
quas
sioid
es
Sim
arou
bace
ae
Aer
ial p
arts
M
eOH
W
eak
Oh
et a
l., 1
997
Picr
orhi
za k
urro
a Sc
roph
ular
iace
ae
Rhi
zom
e M
eOH
In
activ
e O
h et
al.,
199
7
438
Natural products inhibitors of the angiotensin converting enzyme (ACE). A review between 1980 - 2000
Rev. Bras. Farmacogn.Braz J. Pharmacogn.
16(3):jul/set. 2006
Pine
llia
tern
ata
Ara
ceae
D
ried
rhiz
ome
Tube
r H
2O
MeO
H
Act
ive
Inac
tive
Han
et a
l., 1
991
Oh
et a
l., 1
997
Pinu
s pin
astr
e Pi
nace
ae
Drie
d ba
rk
Flav
onoi
d fr
actio
n In
activ
e B
lasz
o et
al.,
199
6 Pi
nus t
abul
aefo
rmis
Pi
nace
ae
Aer
ial p
arts
M
eOH
In
activ
e O
h et
al.,
199
7 Pi
per f
utok
adsu
ra
Pipe
race
ae
Drie
d ae
rial p
arts
H2O
A
ctiv
e H
an e
t al.,
199
1 Pi
ptop
orus
bet
ulin
us
Poly
pora
ceae
D
ried
orga
nism
H
2O
Inac
tive
Mel
zig
et a
l., 1
996
Pist
acia
lent
iscus
A
naca
rdia
ceae
D
ried
aeria
l par
ts Fl
avon
oid
frac
tion
Act
ive
Sanz
et a
l., 1
993
Plan
tago
asia
tica
Plan
tagi
nace
ae
Drie
d se
ed
Entir
e pl
ant
Entir
e pl
ant
Entir
e pl
ant
H2O
A
ceto
ne
EtO
H (9
5%)
H2O
Equi
voca
l A
ctiv
e A
ctiv
e A
ctiv
e
Han
et a
l., 1
991
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Plan
tago
sp.
Plan
tagi
nace
ae
Drie
d le
af
Drie
d se
ed
MeO
H-H
2O (1
:1)
MeO
H-H
2O (1
:1)
Inac
tive
Inac
tive
Inok
uchi
et a
l., 1
984
Inok
uchi
et a
l., 1
984
Plat
ycar
ya st
robi
liace
ae
Jugl
anda
ceae
Fr
uit
MeO
H
Inac
tive
Oh
et a
l., 1
997
Plat
ycod
on g
radi
floru
m
Cam
panu
lace
ae
Roo
t R
oot
Roo
t
CH
Cl 3
H2O
M
eOH
Wea
k W
eak
Inac
tive
Oh
et a
l., 1
997
Oh
et a
l., 1
997
Oh
et a
l., 1
997
Pleu
rotu
s saj
or-c
ajo
Poly
pora
ceae
Fr
uitb
ody
Not
stat
ed
Act
ive
Ikem
izu
et a
l., 1
995
Poly
gala
tenu
ifolia
Po
lyga
lace
ae
Roo
t D
ried
root
M
eOH
H
2O
Inac
tive
Equi
voca
l O
h et
al.,
199
7 H
an e
t al.,
199
1 Po
lygo
natu
m a
vicu
lare
Li
liace
ae
Drie
d ae
rial p
arts
D
ried
entir
e pl
ant
Drie
d en
tire
plan
t
Tann
in fr
actio
n C
hrom
atog
. fra
ctio
n M
eOH
-H2O
(1:1
)
Act
ive
Inac
tive
Act
ive
Inok
uchi
et a
l., 1
985
Inok
uchi
et a
l., 1
984
Inok
uchi
et a
l., 1
984
Poly
gona
tum
sirib
icum
Li
liace
ae
Drie
d riz
hom
e D
ried
rizho
me
MeO
H-H
2O (1
:1)
H2O
In
activ
e In
activ
e In
okuc
hi e
t al.,
198
4 H
an e
t al.,
199
1 Po
lygo
num
mul
tiflo
rum
Po
lyga
lace
ae
Roo
t D
ried
root
M
eOH
H
2O
Inac
tive
Act
ive
Oh
et a
l., 1
997
Han
et a
l., 1
991
Poly
gonu
m th
unbe
rgii
Poly
gala
ceae
A
eria
l par
ts
MeO
H
Inac
tive
Oh
et a
l., 1
997
Poly
poru
s squ
amos
us
Poly
pora
ceae
D
ried
orga
nism
H
2O
Wea
k M
elzi
g et
al.,
199
6 Po
ria
coco
s Po
lypo
race
ae
Drie
d or
gani
sm
H2O
Eq
uivo
cal
Han
et a
l., 1
991
Pote
ntill
a ch
inen
sis
Ros
acea
e D
ried
aeria
l par
ts Ta
nnin
frac
tion
Act
ive
Inok
uchi
et a
l., 1
985
Pote
ntill
a cr
ytot
aeni
ae
Ros
acea
e A
eria
l par
ts
MeO
H
Inac
tive
Oh
et a
l., 1
997
Pote
ntill
a sp
. R
osac
eae
Drie
d en
tire
plan
t D
ried
entir
e pl
ant
Chr
omat
og. f
ract
ion
MeO
H-H
2O (1
:1)
Act
ive
Act
ive
Inok
uchi
et a
l., 1
984
Inok
uchi
et a
l., 1
984
Prun
ella
vul
garis
La
mia
ceae
A
eria
l par
ts
Drie
d ae
rial p
arts
D
ried
inflo
res.
MeO
H
H2O
M
eOH
-H2O
(1:1
)
Wea
k W
eak
Inac
tive
Oh
et a
l., 1
997
Han
et a
l., 1
991
Inok
uchi
et a
l., 1
984
Prun
us m
ume
Ros
acea
e Fr
uit
MeO
H
Inac
tive
Oh
et a
l., 1
997
Pseu
dart
hria
hoo
keri
Fa
bace
ae
Roo
t R
oot
Roo
t
Ace
tone
Et
OH
(95%
) H
2O
Act
ive
Stro
ng
Wea
k
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
439
José M. Barbosa-Filho, Valeska K.M. Martins, Luiza A. Rabelo, et al.
Rev. Bras. Farmacogn.Braz J. Pharmacogn.16(3):jul/set. 2006
Pseu
dart
hria
vis
cida
Fa
bace
ae
Roo
t R
oot
Roo
t
Ace
tone
Et
OH
(95%
) H
2O
Wea
k A
ctiv
e A
ctiv
e
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Psor
alea
cor
ylifo
lia
Faba
ceae
D
ried
fruit
H2O
W
eak
Han
et a
l., 1
991
Puer
aria
loba
ta
Faba
ceae
D
ried
root
R
oot
Roo
t
H2O
A
ceto
ne
EtO
H (9
5%)
Wea
k W
eak
Act
ive
Han
et a
l., 1
991
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Puer
aria
pse
udo-
hisu
ta
Faba
ceae
D
ried
root
M
eOH
-H2O
(1:1
) In
activ
e In
okuc
hi e
t al.,
198
4 Pu
lsat
illa
chin
ensis
R
anun
cula
ceae
D
ried
aeria
l par
ts
H2O
In
activ
e H
an e
t al.,
199
1 Py
rola
japo
nica
Py
rola
ceae
A
eria
l par
ts
MeO
H
Inac
tive
Oh
et a
l., 1
997
Pyrr
osia
ling
ua
Poly
podi
acea
e En
tire
plan
t En
tire
plan
t En
tire
plan
t
Ace
tone
Et
OH
(95%
) H
2O
Act
ive
Act
ive
Act
ive
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Qui
ncha
mal
ium
chi
lens
e Sa
ntal
acea
e A
eria
l par
ts
EtO
H (9
5%)
Act
ive
Han
sen
et a
l., 1
995
Ranu
ncul
us ja
poni
cus
Ran
uncu
lace
ae
Aer
ial p
arts
M
eOH
In
activ
e O
h et
al.,
199
7 Ra
uvol
fia se
rpen
tina
Apo
cyna
ceae
D
ried
root
M
eOH
-H2O
(1:1
) In
activ
e In
okuc
hi e
t al.,
198
4 Re
hman
nia
glut
inos
a Sc
roph
ular
iace
ae
Drie
d ro
ot
H2O
W
eak
Han
199
1 Rh
eum
pal
mat
um
Poly
gona
ceae
D
ried
rhiz
ome
Rhi
zom
e Ta
nnin
frac
tion
MeO
H
Act
ive
Wea
k In
okuc
hi e
t al.,
198
5 O
h et
al.,
199
7 Rh
eum
sp.
Poly
gona
ceae
D
ried
rhiz
ome
Drie
d rh
izom
e C
hrom
atog
. fra
ctio
n M
eOH
-H2O
(1:1
) A
ctiv
e A
ctiv
e In
okuc
hi e
t al.,
198
4 In
okuc
hi e
t al.,
198
4 Ro
sa m
ultif
lora
R
osac
eae
Frui
t M
eOH
In
activ
e O
h et
al.,
199
7 Sa
lvia
milt
iorr
hiza
La
mia
ceae
D
ried
root
R
oot
MeO
H-H
2O (1
:1)
MeO
H
Inac
tive
Inac
tive
Inok
uchi
et a
l., 1
984
Oh
et a
l., 1
997
Sang
uiso
rba
offic
inal
is
Ros
acea
e D
ried
root
M
eOH
-H2O
(1:1
) A
ctiv
e In
okuc
hi e
t al.,
198
4 Sa
pium
sebi
feru
m
Euph
orbi
acea
e R
oot
MeO
H
Inac
tive
Oh
et a
l., 1
997
Sasa
bor
ealis
Po
acea
e A
eria
l par
ts
MeO
H
Inac
tive
Oh
et a
l., 1
997
Saus
sure
a la
ppa
Ast
erac
eae
Drie
d ro
ot
Roo
t M
eOH
-H2O
(1:1
) M
eOH
A
ctiv
e In
activ
e In
okuc
hi e
t al.,
198
4 O
h et
al.,
199
7 Sc
hinu
s lat
ifoliu
s A
naca
rdia
ceae
B
ark
Bar
k B
ark
Bar
k
BuO
H
EtO
Ac
EtO
H (9
5%)
EtO
H- H
2O (7
:3)
Act
ive
Act
ive
Act
ive
Act
ive
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Schi
zone
peta
tenu
ifolia
La
mia
ceae
D
ried
aeria
l par
ts H
2O
Equi
voca
l H
an e
t al.,
199
1 Sc
roph
ular
ia n
ingp
oens
is Sc
roph
ular
iace
ae
Drie
d ro
ot
Roo
t M
eOH
-H2O
(1:1
) M
eOH
In
activ
e In
activ
e In
okuc
hi e
t al.,
198
4 O
h et
al.,
199
7 Sc
utel
lari
a ba
ical
ensis
La
mia
ceae
D
ried
root
R
oot
Roo
t R
oot
MeO
H-H
2O (1
:1)
CH
Cl 3
H2O
M
eOH
Inac
tive
Wea
k W
eak
Wea
k
Inok
uchi
et a
l., 1
984
Oh
et a
l., 1
997
Oh
et a
l., 1
997
Oh
et a
l., 1
997
440
Natural products inhibitors of the angiotensin converting enzyme (ACE). A review between 1980 - 2000
Rev. Bras. Farmacogn.Braz J. Pharmacogn.
16(3):jul/set. 2006
Sedu
m sa
rmen
tosu
m
Cra
ssul
acea
e En
tire
plan
t En
tire
plan
t En
tire
plan
t
Ace
tone
Et
OH
(95%
) H
2O
Act
ive
Act
ive
Act
ive
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Sida
acu
ta
Mal
vace
ae
Roo
t R
oot
Roo
t
Ace
tone
Et
OH
(95%
) H
2O
Act
ive
Wea
k A
ctiv
e
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Sida
cor
difo
lia
Mal
vace
ae
Roo
t R
oot
Roo
t
Ace
tone
Et
OH
(95%
) H
2O
Act
ive
Wea
k A
ctiv
e
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Sida
retu
sa
Mal
vace
ae
Roo
t R
oot
Roo
t
Ace
tone
Et
OH
(95%
) H
2O
Act
ive
Wea
k A
ctiv
e
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Sige
sbec
kia
orie
ntal
is
Ast
erac
eae
Drie
d ae
rial p
arts
R
hizo
me
MeO
H
H2O
In
activ
W
eak
Oh
et a
l., 1
997
Han
et a
l., 1
991
Smila
x ch
ina
Lilia
ceae
R
hizo
me
MeO
H
Inac
tive
Oh
et a
l., 1
997
Sino
men
ium
acu
tum
M
enis
perm
acea
e D
ried
root
R
hizo
me
Rhi
zom
e +
stem
H2O
M
eOH
M
eOH
-H2O
(1:1
)
Act
ive
Inac
tive
Inac
tive
Han
et a
l., 1
991
Oh
et a
l., 1
997
Inok
uchi
et a
l., 1
984
Sola
num
nig
rum
So
lana
ceae
D
ried
aeria
l par
ts H
2O
Act
ive
Han
et a
l., 1
991
Solid
ago
virg
aure
a A
ster
acea
e A
eria
l par
ts
MeO
H
Inac
tive
Oh
et a
l., 1
997
Soph
ora
flave
scen
s Fa
bace
ae
Roo
t M
eOH
In
activ
e O
h et
al.,
199
7 So
phor
a ja
poni
ca
Faba
ceae
Fl
ower
M
eOH
In
activ
e O
h et
al.,
199
7 So
phor
a su
bpro
stata
Fa
bace
ae
Drie
d ro
ot
Roo
t H
2O
MeO
H
Wea
k In
activ
e H
an e
t al.,
199
1 O
h et
al.,
199
7 So
rbus
am
uren
sis
Ros
acea
e B
ark
MeO
H
Inac
tive
Oh
et a
l., 1
997
Spar
gani
um st
olon
iferu
m
Spar
gani
acea
e D
ried
root
R
hizo
me
H2O
M
eOH
W
eak
Inac
tive
Han
et a
l., 1
991
Oh
et a
l., 1
997
Spat
holo
bus s
uber
ectu
s Fa
bace
ae
Drie
d st
em
H2O
In
activ
e H
an e
t al.,
199
1 St
emon
a ja
poni
ca
Stem
onac
eae
Roo
t M
eOH
In
activ
e O
h et
al.,
199
7 St
emon
a se
ssili
folia
St
emon
acea
e D
ried
root
H
2O
Inac
tive
Han
et a
l., 1
991
Step
hana
ndra
inci
sa
Ros
acea
e A
eria
l par
ts
MeO
H
Inac
tive
Oh
et a
l., 1
997
Stry
chno
s nux
-vom
ica
Loga
niac
eae
Seed
M
eOH
In
activ
e O
h et
al.,
199
7 St
yrax
japo
nicu
s St
yrac
acea
e A
eria
l par
ts
MeO
H
Inac
tive
Oh
et a
l., 1
997
Sym
ploc
os c
hine
nsis
Sypl
ocac
eae
Aer
ial p
arts
M
eOH
In
activ
e O
h et
al.,
199
7 Ta
raxa
cum
mon
golic
um
Ast
erac
eae
Aer
ial p
arts
A
eria
l par
ts
Aer
ial p
arts
D
ried
flow
ers
CH
Cl 3
H2O
M
eOH
H
2O
Wea
k In
activ
e W
eak
Equi
voca
l
Oh
et a
l., 1
997
Oh
et a
l., 1
997
Oh
et a
l., 1
997
Han
et a
l , 1
991
Taxu
s cus
pida
ta
Taxa
ceae
A
eria
l par
ts
MeO
H
Inac
tive
Oh
et a
l., 1
997
Thuj
a or
ient
alis
C
upre
ssac
eae
Drie
d se
ed
Leaf
H
2O
MeO
H
Inac
tive
Inac
tive
Han
et a
l., 1
991
Oh
et a
l., 1
997
441
José M. Barbosa-Filho, Valeska K.M. Martins, Luiza A. Rabelo, et al.
Rev. Bras. Farmacogn.Braz J. Pharmacogn.16(3):jul/set. 2006
Toril
is ja
poni
ca
Api
acea
e Fr
uit
Frui
t C
HC
l 3 H
2O
Wea
k In
activ
e O
h et
al.,
199
7 O
h et
al.,
199
7 To
rrey
a nu
cife
ra
Taxa
ceae
Se
ed
MeO
H
Inac
tive
Oh
et a
l., 1
997
Trac
hom
itum
ven
etum
A
pocy
nace
ae
Drie
d en
tire
plan
t M
eOH
-H2O
(1:1
) In
activ
e In
okuc
hi e
t al.,
198
4 Tr
achy
carp
us e
xelsu
s A
raca
ceae
D
ried
leaf
M
eOH
-H2O
(1:1
) In
activ
e In
okuc
hi e
t al.,
198
4 Tr
amet
es h
irsut
a
Poly
pora
ceae
D
ried
orga
nism
H
2O
Inac
tive
Mel
zig
et a
l., 1
996
Tram
etes
ver
sicol
or
Poly
pora
ceae
D
ried
orga
nism
H
2O
Inac
tive
Mel
zig
et a
l., 1
996
Tric
hosa
nthe
s kiri
lowi
i C
ucur
bita
ceae
D
ried
fruit
Roo
t H
2O
MeO
H
Act
ive
Inac
tive
Han
et a
l., 1
991
Oh
et a
l., 1
997
Tric
holo
ma
popu
linum
Tr
icho
lom
atac
eae
Drie
d or
gani
sm
H2O
In
activ
e M
elzi
g et
al.,
199
6 Tr
icho
lom
a po
rten
tosu
m
Tric
holo
mat
acea
e D
ried
orga
nism
H
2O
Inac
tive
Mel
zig
et a
l., 1
996
Tric
holo
psis
rutil
ans
Tric
holo
mat
acea
e D
ried
orga
nism
H
2O
Inac
tive
Mel
zig
et a
l., 1
996
Triu
mfe
tta rh
ombo
idea
Ti
liace
ae
Roo
t R
oot
Roo
t
Ace
tone
Et
OH
(95%
) H
2O
Wea
k A
ctiv
e A
ctiv
e
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Trop
aeol
um m
ajus
Tr
opae
olac
eae
Drie
d ae
rial
H2O
W
eak
Han
et a
l., 1
991
Tuss
ilago
farfa
ra
Ast
erac
eae
Drie
d flo
wer
s H
2O
Inac
tive
Han
et a
l., 1
991
Ulm
us p
arvi
folia
U
lmac
eae
Roo
t M
eOH
In
activ
e O
h et
al.,
199
7 U
ncar
ia rh
ynch
ophy
lla
Rub
iace
ae
Drie
d br
anch
ets
Roo
t R
oot
Roo
t
MeO
H-H
2O (1
:1)
Ace
tone
Et
OH
(95%
) H
2O
Act
ive
Act
ive
Act
ive
Act
ive
Inok
uchi
et a
l., 1
984
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Han
sen
et a
l., 1
995
Vacc
aria
sega
talis
C
aryo
phyl
lace
ae
Drie
d se
ed
H2O
W
eak
Han
et a
l., 1
991
Verb
ena
offic
inal
is V
erbe
nace
ae
Drie
d ae
rial p
arts
H2O
Eq
uivo
cal
Han
et a
l., 1
991
Vero
nica
strum
sibi
ricum
Sc
roph
ular
iace
ae
Aer
ial p
arts
M
eOH
In
activ
e O
h et
al.,
199
7 Vi
burn
um o
pulu
s C
aprif
olia
ceae
D
ried
bark
Et
OH
-H2O
(1:1
) A
ctiv
e Jo
nade
r et a
l., 1
989
Vitis
vin
ifera
V
itace
ae
Drie
d fru
it Fl
avon
oid
frac
tion
Act
ive
Meu
nier
et a
l., 1
987
Volv
arie
lla sp
ecio
sa
Plut
eace
ae
Drie
d or
gani
sm
H2O
W
eak
Mel
zig
et a
l., 1
996
Xant
hium
sibi
ricum
A
ster
acea
e D
ried
seed
H
2O
Equi
voca
l H
an e
t al.,
199
1 Xa
nthi
um st
rum
ariu
m
Ast
erac
eae
Drie
d fru
it Fr
uit
MeO
H-H
2O (1
:1)
MeO
H
Inac
tive
Inac
tive
Inok
uchi
et a
l., 1
984
Oh
et a
l., 1
997
Xyla
ria p
olym
orph
a X
ylar
iace
ae
Drie
d or
gani
sm
H2O
In
activ
e M
elzi
g et
al.,
199
6 Yo
ungi
a ja
poni
ca
Ast
erac
eae
Aer
ial p
arts
M
eOH
In
activ
e O
h et
al.,
199
7 Za
thox
ylum
pip
eritu
m
Rut
acea
e Fr
uit
MeO
H
Inac
tive
Oh
et a
l., 1
997
Zing
iber
offi
cina
le
Zing
iber
acea
e R
hizo
me
MeO
H
Inac
tive
Oh
et a
l., 1
997
Zizip
hus j
ujub
a R
ham
nace
ae
Frui
t M
eOH
W
eak
Oh
et a
l., 1
997
Zizip
hus s
pino
sa
Rha
mna
ceae
D
ried
seed
M
eOH
-H2O
(1:1
) In
activ
e O
h et
al.,
199
7
442
Natural products inhibitors of the angiotensin converting enzyme (ACE). A review between 1980 - 2000
Rev. Bras. Farmacogn.Braz J. Pharmacogn.
16(3):jul/set. 2006
Tabl
e 4.
Che
mic
ally
defi
ned
nat
ural
com
poun
ds sh
owin
g in
hibi
tion
of a
ngio
tens
in c
onve
rting
enz
yme
Che
mic
al n
ame
C
lass
So
urce
A
ctiv
ity
Ref
eren
ce
Act
inom
adur
a an
tibio
tic 1
5B1
Prot
eid
Actin
omad
ura
sp.
Act
ive
Kid
o et
al.,
198
4 A
ctin
omad
ura
antib
iotic
15B
2 Pr
otei
d Ac
tinom
adur
a sp
. A
ctiv
e K
ido
et a
l., 1
984
Act
inom
yces
ant
ibio
tic 1
582
Prot
eid
Actin
omyc
es sp
. A
ctiv
e K
ido,
et a
l., 1
985
Act
inom
yces
ant
ibio
tic K
-26
Prot
eid
Actin
omyc
es sp
. A
ctiv
e Y
amat
o et
al.,
198
6 A
fzel
in
Flav
onoi
d Er
ythr
oxyl
um la
urifo
lium
A
ctiv
e H
anse
n et
al.,
199
5 A
lism
ol
Sesq
uite
rpen
e Al
isma
orie
ntal
e In
activ
e Y
amah
ara
et a
l., 1
989
Anc
oven
in
Prot
eid
Stre
ptom
yces
sp.
Stre
ptom
yces
sp.
Act
ive
Act
ive
Kid
o et
al.,
198
3 W
akam
iya
et a
l., 1
985
Ang
iote
nsin
com
poun
d Pr
otei
d Vi
pera
asp
is as
pis
Act
ive
Kom
ori e
t al.,
199
0 A
niso
mel
ic a
cid
Dite
rpen
e An
isom
eles
indi
ca
Wea
k M
omos
e et
al.,
199
4 A
niso
mel
ic a
cid,
4-m
ethy
lene
-5-o
xo
Dite
rpen
e An
isom
eles
indi
ca
Inac
tive
Aris
awa
et a
l., 1
986
Arg
inin
e, L
Pr
otei
d C
omm
erci
al
Act
ive
Hig
ashi
et a
l., 1
995
Arr
ivac
in A
Se
squi
terp
ene
Ambr
osia
psil
osta
chya
A
ctiv
e C
hen
et a
l., 1
991
Arr
ivac
in B
Se
squi
terp
ene
Ambr
osia
psil
osta
chya
A
ctiv
e C
hen
et a
l., 1
991
Arp
ham
enin
e B
A
lkal
oid
Chro
mob
acte
rium
vio
lace
um
Inac
tive
Aoy
agi e
t al.,
198
6 A
sper
gillo
mar
asm
ine
A
Prot
eid
Aspe
rgill
us o
ryza
e A
ctiv
e M
ikam
i et a
l., 1
983
Asp
ergi
llom
aras
min
e B
Pr
otei
d As
perg
illus
ory
zae
Act
ive
Mik
ami e
t al.,
198
3 A
sper
osid
e C
arde
nolid
e Eu
com
mia
ulm
oide
s A
ctiv
e Y
amad
aki e
t al.,
199
2 A
stra
galin
Fl
avon
oid
Dio
spyr
os k
aki
Act
ive
Kam
eda
et a
l., 1
987
Atra
ctyl
enol
ide
I Se
squi
terp
ene
Atra
ctyl
oide
s jap
onic
a In
activ
e Sa
kura
i et a
l., 1
993
Atra
ctyl
enol
ide
III
Sesq
uite
rpen
e At
ract
yloi
des j
apon
ica
Inac
tive
Saku
rai e
t al.,
199
3 A
tract
ylod
inol
O
xyge
n he
tero
cycl
e At
ract
yloi
des j
apon
ica
Act
ive
Saku
rai e
t al.,
199
3 A
tract
ylon
e Se
squi
terp
ene
Atra
ctyl
oide
s jap
onic
a In
activ
e Sa
kura
i et a
l., 1
993
Ber
geni
n C
oum
arin
Al
loph
ylus
edu
lis
Inac
tive
Aris
awa
et a
l., 1
989
Bes
tatin
Pr
otei
d St
rept
omyc
es o
livor
etic
uli
Inac
tive
Aoy
agi e
t al.,
198
6 C
apsi
anos
ide
A
Dite
rpen
e Ca
psic
um sp
p.
Act
ive
Yah
ara
et a
l., 1
990
Cap
sian
osid
e C
D
iterp
ene
Caps
icum
spp.
A
ctiv
e Iz
umita
ni e
t al.,
199
0 C
apsi
anos
ide
I D
iterp
ene
Caps
icum
spp.
W
eak
Yah
ara
et a
l., 1
990
Cap
sian
osid
e II
Dite
rpen
e Ca
psic
um sp
p.
Inac
tive
Yah
ara
et a
l., 1
990
Cat
echi
n, (+
) Fl
avon
oid
Allo
phyl
us e
dulis
Al
loph
ylus
edu
lis
Act
ive
Inac
tive
Cho
et a
l., 1
993
Inok
uchi
et a
l., 1
996b
C
atec
hin,
epi
(-)
Flav
onoi
d Al
loph
ylus
edu
lis
Arec
a ca
tech
u In
activ
e In
activ
e In
okuc
hi, e
t al.,
199
6b
Aris
awa,
et a
l., 1
989
Cat
echi
n-3-
O-g
alla
te, e
pi (-
) Fl
avon
oid
Kor
ean
gree
n te
a K
orea
n gr
een
tea
Act
ive
Act
ive
Cho
et a
l., 1
993
Uch
ida
et a
l., 1
987
Coc
hinm
icin
I Pr
otei
d M
icro
bisp
ora
sp.
Inac
tive
Lam
et a
l., 1
992
Coc
hinm
icin
II
Prot
eid
Mic
robi
spor
a sp
. W
eak
Lam
et a
l., 1
992
Coc
hinm
icin
III
Prot
eid
Mic
robi
spor
a sp
. W
eak
Lam
et a
l., 1
992
Cor
ilagi
n Ta
nnin
Ph
ylla
nthu
s niru
ri A
ctiv
e U
eno
et a
l., 1
988
443
José M. Barbosa-Filho, Valeska K.M. Martins, Luiza A. Rabelo, et al.
Rev. Bras. Farmacogn.Braz J. Pharmacogn.16(3):jul/set. 2006
Cor
iolic
aci
d, (D
L)
Lipi
d Fr
ittila
ria v
ertic
illat
a A
ctiv
e N
iitsu
et a
l., 1
987
Cyc
loan
isom
elic
aci
d, 4
,7-o
xy
Dite
rpen
e An
isom
eles
indi
ca
Inac
tive
Aris
awa
et a
l., 1
986
Cym
ene,
allo
M
onot
erpe
ne
Com
mer
cial
W
eak
Oka
mur
a et
al.,
199
2 C
ytos
porin
A
Oxy
gen
hete
rocy
cle
Cyto
spor
a sp
. A
ctiv
e St
even
s-M
iles e
t al.,
199
6 C
ytos
porin
B
Oxy
gen
hete
rocy
lle
Cyto
spor
a sp
. W
eak
Stev
ens-
Mile
s et a
l., 1
996
Cyt
ospo
rin C
O
xyge
n he
tero
cycl
e Cy
tosp
ora
sp.
Wea
k St
even
s-M
iles e
t al.,
199
6 D
aphn
odor
in A
Fl
avon
oid
Dap
hne
odor
a A
ctiv
e Ta
kai e
t al.,
199
9 D
aphn
odor
in B
Fl
avon
oid
Dap
hne
odor
a A
ctiv
e Ta
kai e
t al.,
199
9 D
aphn
odor
in C
Fl
avon
oid
Dap
hne
odor
a In
activ
e Ta
kai e
t al.,
199
9 D
imor
phec
olic
aci
d, a
lpha
Li
pid
Lyci
um c
hine
nse
Act
ive
Mor
ota
et a
l., 1
987
Dim
orph
ecol
ic a
cid,
alp
ha (D
L)
Lipi
d Fr
ittila
ria v
ertic
illat
a A
ctiv
e N
iitsu
et a
l., 1
987
Dim
orph
ecol
ic a
cid,
bet
a (D
L)
Lipi
d Fr
ittila
ria v
ertic
illat
a A
ctiv
e N
iitsu
et a
l., 1
987
Dor
atom
yces
ant
ibio
tic W
F-10
129
Prot
eid
Dor
atom
yces
put
redi
nis
Act
ive
And
o et
al.,
198
7 El
lagi
c ac
id
Cou
mar
in
Phyl
lant
hus n
iruri
Act
ive
Uen
o et
al.,
198
8 Ev
ocar
pine
A
lkal
oid
Evod
ia ru
taec
arpa
A
ctiv
e Le
e et
al.,
199
8 Ex
cels
iosi
de
Irido
id
Flax
inus
exc
elsio
r In
activ
e H
anse
n et
al.,
199
6a
Fago
pyru
m tr
ipep
tide
Prot
eid
Fago
pyru
m sp
. A
ctiv
e K
oyam
a et
al.,
199
3 Fa
ngch
inol
ium
hyd
roxi
de
Alk
aloi
d St
epha
nia
tetra
ndra
A
ctiv
e O
gino
et a
l., 1
986
Fenf
angj
ine
F A
lkal
oid
Step
hani
a te
trand
ra
Act
ive
Ogi
no e
t al.,
199
8 Fe
nfan
gjin
e G
A
lkal
oid
Step
hani
a te
trand
ra
Inac
tive
Ogi
no e
t al.,
199
8 Fe
nfan
gjin
e H
A
lkal
oid
Step
hani
a te
trand
ra
Act
ive
Ogi
no e
t al.,
199
8 Fe
nfan
gjin
e I
Alk
aloi
d St
epha
nia
tetra
ndra
A
ctiv
e O
gino
et a
l., 1
998
Ficu
s ol
igop
eptid
e FL
P-1
Prot
eid
Ficu
s car
ica
Act
ive
Mar
uyam
a et
al.,
199
0 Fi
cus
olig
opep
tide
FLP-
2 Pr
otei
d Fi
cus c
aric
a A
ctiv
e M
aruy
ama
et a
l., 1
990
Ficu
s ol
igop
eptid
e FL
P-3
Prot
eid
Ficu
s car
ica
Act
ive
Mar
uyam
a et
al.,
199
0 Fi
cus p
eptid
e FL
P-1
Prot
eid
Ficu
s car
ica
Act
ive
Mar
uyam
a et
al.,
198
9 Fi
cus p
eptid
e FL
P-2
Prot
eid
Ficu
s car
ica
Act
ive
Mar
uyam
a et
al.,
198
9 Fi
cus p
eptid
e FL
P-3
Prot
eid
Ficu
s car
ica
Act
ive
Mar
uyam
a et
al.,
198
9 Fi
setin
Fl
avon
oid
Com
mer
cial
A
ctiv
e Li
n et
al.,
199
4 G
allic
aci
d B
enze
noid
Ph
ylla
nthu
s niru
ri A
ctiv
e U
eno
et a
l., 1
988
Gal
loca
tech
in, (
+)
Flav
onoi
d K
orea
n gr
een
tea
Act
ive
Cho
et a
l., 1
993
Gal
loca
tech
in, e
pi (-
) Fl
avon
oid
Kor
ean
gree
n te
a A
ctiv
e C
ho e
t al.,
199
3 G
allo
cate
chin
, epi
, 3-O
-gal
late
(-)
Flav
onoi
d K
orea
n gr
een
tea
Act
ive
Uch
ida
et a
l., 1
987
Gal
loca
tech
in-3
-O-g
alla
te (-
), ep
i (-)
Fl
avon
oid
Kor
ean
gree
n te
a A
ctiv
e C
ho e
t al.,
199
3 G
eran
iin
Tann
in
Phyl
lant
hus n
iruri
Alop
hylu
s edu
lis
Act
ive
Act
ive
Uen
o et
al.,
198
8 A
risaw
a et
al.,
198
9 G
lu-A
sn-T
rp, P
Pr
otei
d Tr
imer
esur
us fl
avov
iridi
s Tr
imer
esur
us o
kina
vens
is In
activ
e In
activ
e M
aeda
et a
l., 1
993
Mae
da e
t al.,
199
3 G
lu-G
ln-T
rp, P
Pr
otei
d Tr
imer
esur
us fl
avov
iridi
s Tr
imer
esur
us o
kina
vens
is In
activ
e In
activ
e M
aeda
et a
l., 1
993
Mae
da e
t al.,
199
3
444
Natural products inhibitors of the angiotensin converting enzyme (ACE). A review between 1980 - 2000
Rev. Bras. Farmacogn.Braz J. Pharmacogn.
16(3):jul/set. 2006
Glu
-Lys
-Trp
, P
Prot
eid
Trim
eres
urus
flav
oviri
dis
Trim
eres
urus
oki
nave
nsis
Wea
k W
eak
Mae
da e
t al.,
199
3 M
aeda
et a
l., 1
993
Gos
sypo
l Se
squi
terp
ene
Gos
sypi
um sp
. A
ctiv
e K
rass
nigg
et a
l., 1
984
Kae
mpf
erol
-3-O
-gal
loyl
-glu
cose
Fl
avon
oid
Dio
spyr
os k
aki
Act
ive
Kam
eda
et a
l., 1
987
Kap
akah
ine
A
Prot
eid
Crib
roch
alin
a ol
emda
In
activ
e Y
eung
et a
l., 1
996
Lano
sten
(20-
R)
Trite
rpen
e Sc
hinu
s mol
le
Act
ive
Ola
fsso
n et
al.,
199
7 La
nost
en (2
0-S)
Tr
iterp
ene
Schi
nus m
olle
A
ctiv
e O
lafs
son
et a
l., 1
997
Ligs
trosi
de
Irido
id
Ligu
strum
japo
nicu
m
Inac
tive
Han
sen
et a
l., 1
996a
Li
gust
alos
ide
B
Mon
oter
pene
Li
gustr
um ja
poni
cum
In
activ
e H
anse
n et
al.,
199
6a
Lirio
dend
rin
Lign
an
Euco
mm
ia u
lmoi
des
Act
ive
Yam
adak
i et a
l., 1
992
Lyci
umin
A
Prot
eid
Lyci
um c
hine
nse
Lyci
um c
hine
nse
Act
ive
Act
ive
Yah
ara
et a
l., 1
989
Mor
ita e
t al.,
199
6 Ly
cium
in B
Pr
otei
d Ly
cium
chi
nens
e Ly
cium
chi
nens
e A
ctiv
e A
ctiv
e Y
ahar
a et
al.,
198
9 Y
ahar
a et
al.,
199
3 M
icro
gini
n Pr
otei
d M
icro
cysti
s aer
ugin
osa
Act
ive
Oki
no e
t al.,
199
3 M
icro
gini
n 29
9-C
Pr
otei
d M
icro
cysti
s aer
ugin
osa
Inac
tive
Ishi
da e
t al.,
199
8 M
icro
gini
n 29
9-D
Pr
otei
d M
icro
cysti
s aer
ugin
osa
Inac
tive
Ishi
da e
t al.,
199
8 M
icro
mon
ospo
ra A
CE
K-1
3 Pr
otei
d M
icro
mon
ospo
ra h
alop
hytic
a A
ctiv
e K
ase
et a
l., 1
987
Mol
ihua
side
A
Irido
id
Jasm
inum
azo
ricum
A
ctiv
e So
man
adha
n et
al.,
199
8 M
onoc
rota
line
Alk
aloi
d Cr
otal
aria
sp.
Crot
alar
ia sp
. In
activ
e A
ctiv
e La
fran
coni
et a
l., 1
983
Mol
teni
et a
l., 1
984
Mor
roni
side
Iri
doid
Sa
mbu
cus n
igra
In
activ
e H
anse
n et
al.,
199
6a
Mur
acei
n A
Pr
otei
d No
card
ia o
rien
talis
A
ctiv
e Si
ngh
et a
l., 1
984
Mur
acei
n B
Pr
otei
d No
card
ia o
rien
talis
A
ctiv
e Si
ngh
et a
l., 1
984
Mur
acei
n C
Pr
otei
d No
card
ia o
rien
talis
A
ctiv
e Si
ngh
et a
l., 1
984
Myr
cene
M
onot
erpe
ne
Com
erci
al
Act
ive
Oka
mur
a et
al.,
199
2 M
yric
eron
-caf
eoyl
-est
er
Trite
rpen
e M
yric
a ce
rifer
a In
activ
e Fu
jimot
o et
al.,
199
2 N
icot
inam
ide
Prot
eid
Soy
sauc
e Co
rcho
rus o
litor
ius
Act
ive
Act
ive
Kin
oshi
ta e
t al.,
199
3 K
imot
o et
al.,
199
8 N
onan
oic
acid
, 8(S
)-am
ino-
2(R)
- m
ethy
l-7-o
xo
Prot
eid
Stre
ptom
yces
sp.
Inac
tive
Parn
as e
t al.,
199
6
Nor
athy
riol
Xan
thon
e Tr
ypte
rosp
erm
um la
nceo
latu
m
Act
ive
Sutte
r ; W
ang,
199
3 O
ctad
eca-
10-tr
ans-
12-c
is-15
-cis-
trien
oic
acid
, 9-
hydr
oxy
Lipi
d Ly
cium
chi
nens
is A
ctiv
e M
orot
a et
al.,
198
7
Oct
adec
a-9-
tran
s-11
-tran
s-di
enoi
c ac
id,
13-
hydr
oxy
Lipi
d Fr
itilla
ria v
ertic
illat
a A
ctiv
e N
iitsu
et a
l., 1
987
Ole
acei
n Iri
doid
O
lea
euro
paea
A
ctiv
e H
anse
n et
al.,
199
6a
Ole
osid
e Iri
doid
O
lea
euro
paea
O
lea
lanc
ea
Wea
k W
eak
Han
sen
et a
l., 1
996a
H
anse
n et
al.,
199
6a
Ole
osid
e-11
-met
hyl e
ster
Iri
doid
O
lea
euro
paea
O
lea
lanc
ea
Wea
k W
eak
Han
sen
et a
l., 1
996a
H
anse
n et
al.,
199
6a
445
José M. Barbosa-Filho, Valeska K.M. Martins, Luiza A. Rabelo, et al.
Rev. Bras. Farmacogn.Braz J. Pharmacogn.16(3):jul/set. 2006
Ole
urop
ein
Irido
id
Ole
a eu
ropa
ea
Ole
a la
ncea
W
eak
Wea
k H
anse
n et
al.,
199
6a
Han
sen
et a
l., 1
996a
O
vato
diol
ide
Dite
rpen
e An
isom
eles
indi
ca
Aniso
mel
es in
dica
In
activ
e In
activ
e A
risaw
a et
al.,
198
6 M
omos
e et
al.,
199
4 O
vato
diol
ide,
4,5
-deo
xy
Dite
rpen
e An
isom
eles
indi
ca
Inac
tive
Aris
awa
et a
l., 1
986
Ova
todi
olid
e, 4
,5-e
poxy
D
iterp
ene
Aniso
mel
es in
dica
W
eak
Mom
ose
et a
l., 1
994
Peps
tatin
Pr
otei
d C
omer
cial
A
ctiv
e A
oyag
i et a
l., 1
986
Pept
ide
P Pr
otei
d Bo
thro
ps ja
rara
cuss
u A
ctiv
e Fe
rrei
ra e
t al.,
199
2 Ph
enac
ein
Alk
aloi
d St
rept
omyc
es ta
nash
iens
is
Act
ive
Bus
h et
al.,
198
4 Ph
thal
ide,
3-N
-but
yl
Mis
c la
cton
e Ao
ium
gra
veol
ens
Inac
tive
Tsi e
t al.,
199
7 Po
lysa
ccha
ride
HS-
142-
1 C
arbo
hydr
ate
Aure
obas
idiu
m sp
. In
activ
e M
oris
hita
et a
l., 1
991
Proc
yani
din
B-1
Fl
avon
oid
Lesp
edez
a ca
pita
ta
Act
ive
Wag
ner e
t al.,
199
2 Pr
ocya
nidi
n B
-2, 3
,3’-
di-O
-gal
late
Fl
avon
oid
Kor
ean
gree
n te
a A
ctiv
e U
chid
a et
al.,
198
7 Pr
ocya
nidi
n B
-3
Flav
onoi
d Le
sped
eza
capi
tata
A
ctiv
e W
agne
r et a
l., 1
992
Proc
yani
din
B-3
, 3-O
-gal
late
Fl
avon
oid
Kor
ean
gree
n te
a A
ctiv
e C
ho e
t al.,
199
3 Pr
ocya
nidi
n B
-5, 3
,3’-
di-O
-gal
late
Fl
avon
oid
Kor
ean
gree
n te
a A
ctiv
e U
chid
a et
al.,
198
7 Pr
ocya
nidi
n B
-6
Flav
onoi
d Le
sped
eza
capi
tata
A
ctiv
e W
agne
r et a
l., 1
992
Proc
yani
din
C-1
, 3,3
’,3’’
-tri-O
- ga
llate
Fl
avon
oid
Kor
ean
gree
n te
a A
ctiv
e U
chid
a et
al.,
198
7
Proc
yani
din
C-2
Fl
avon
oid
Lesp
edez
a ca
pita
ta
Act
ive
Wag
ner e
t al.,
199
2 Py
cnid
ione
O
xige
n he
tero
cycl
e Ph
oma
sp.
Inac
tive
Har
ris e
t al.,
199
3 Py
cnog
enol
Fl
avon
oid
Pinu
s mar
itim
a A
ctiv
e Pa
cker
et a
l., 1
999
Que
rcet
in-3
-O-(
2’’-
O-g
allo
yl)-
gluc
osid
e Fl
avon
oid
Dio
spyr
os k
aki
Dio
spyr
os k
aki
Act
ive
Act
ive
Kam
eda
et a
l., 1
987
Aris
awa
et a
l., 1
989
Que
rcet
in-3
-O-b
eta-
D-g
luco
side
Fl
avon
oid
Allo
phyl
us e
dulis
A
ctiv
e A
risaw
a et
al.,
198
9 Q
uerc
itrin
Fl
avon
oid
Eryt
hrox
ylum
laur
ifoliu
m
Act
ive
Han
sen
et a
l., 1
996b
Q
uerc
itrin
, iso
Fl
avon
oid
Dio
spyr
os k
aki
Act
ive
Kam
eda
et a
l., 1
987
Qui
nolo
ne, 1
-met
hyl-2
-[(c
is-4
-cis-
7)-
4,7-
tride
ca-d
ieny
l] A
lkal
oid
Evod
ia ru
taec
arpa
A
ctiv
e Le
e et
al.,
199
8
Qui
nolo
ne,
1-m
ethy
l-2-[p
enta
deca
-cis-
6-ci
s-9-
dien
yl]
Alk
aloi
d Ev
odia
ruta
ecar
pa
Act
ive
Lee
et a
l., 1
998
Sam
bace
in I
Irido
id
Jasm
inum
azo
ricum
A
ctiv
e So
man
adha
n et
al.,
199
8 Sa
mba
cein
II
Irido
id
Jasm
inum
azo
ricum
A
ctiv
e So
man
adha
n et
al.,
199
8 Sa
mba
cein
III
Irido
id
Jasm
inum
azo
ricum
A
ctiv
e So
man
adha
n et
al.,
199
8 Sa
mba
cosi
de A
Iri
doid
Ja
smin
um a
zoric
um
Act
ive
Som
anad
han
et a
l., 1
998
Solla
sin
C
Sesq
uite
rpen
e Po
ecill
astra
solla
si
Act
ive
Kill
day
et a
l., 1
993
Solla
sin
D
Sesq
uite
rpen
e Po
ecill
astra
solla
si
Act
ive
Kill
day
et a
l., 1
993
Stre
ptom
yces
ant
ibio
tic A
-583
65-A
A
lkal
oid
Stre
ptom
yces
chr
omof
uscu
s St
rept
omyc
es c
hrom
ofus
cus
Stre
ptom
yces
chr
omof
uscu
s
Act
ive
Act
ive
Act
ive
Myn
ders
e et
al.,
198
5 M
ynde
rse
et a
l., 1
984
O
’Con
nor e
t al.,
198
5 St
rept
omyc
es a
ntib
iotic
A-5
8365
-B
Alk
aloi
d St
rept
omyc
es c
hrom
ofus
cus
Stre
ptom
yces
chr
omof
uscu
s A
ctiv
e A
ctiv
e M
ynde
rse
et a
l., 1
985
Myn
ders
e et
al.,
198
4
446
Natural products inhibitors of the angiotensin converting enzyme (ACE). A review between 1980 - 2000
Rev. Bras. Farmacogn.Braz J. Pharmacogn.
16(3):jul/set. 2006
Stre
ptom
yces
ant
ibio
tic W
S-73
38-B
Pr
otei
d St
rept
omyc
es sp
. W
eak
Miy
ata
et a
l., 1
992
Stre
ptom
yces
ant
ibio
ticW
S-98
26-A
Pr
otei
d St
rept
omyc
es v
iola
ceus
nige
r W
eak
Has
him
oto
et a
l., 1
992
Syrin
gin
Phen
ylpr
opan
oid
Euco
mm
ia u
lmoi
des
Act
ive
Yam
adak
i et a
l., 1
992
Taxo
l D
iterp
ene
Taxu
s bre
vifo
lia
Act
ive
Saur
u et
al.,
199
5 Te
rpin
ene,
alp
ha
Mon
oter
pene
C
omer
cial
W
eak
Oka
mur
a et
al.,
199
2 Te
rpin
ene,
gam
ma
Mon
oter
pene
C
omer
cial
W
eak
Oka
mur
a et
al.,
199
2 Te
rpin
eol,
alph
a M
onot
erpe
ne
Com
erci
al
Wea
k O
kam
ura
et a
l., 1
992
Tetra
deca
-tran
s-6-
tran
s-12
-die
ne-8
,10-
diyn
e-1,
3-di
ol
Alk
enyn
e At
ract
ylod
es ja
poni
ca
Inac
tive
Saku
rai e
t al.,
199
3
Tetra
deca
-tran
s-6-
tran
s-12
-die
ne-8
,10-
diyn
e-1,
3-di
ol d
iace
tate
A
lken
yne
Atra
ctyl
odes
japo
nica
In
activ
e Sa
kura
i et a
l., 1
993
Tetra
ndrin
e, (+
) A
lkal
oid
Step
hani
a te
trand
ra
Act
ive
Ogi
no e
t al.,
198
7a
Tetra
ndrin
e-2N
-bet
a-ox
ide
Alk
aloi
d St
epha
nia
tetra
ndra
A
ctiv
e O
gino
et a
l., 1
987b
V
arie
colin
Se
ster
terp
ene
Aspe
rgill
us v
arie
colo
r A
ctiv
e H
ense
ns e
t al.,
199
1 V
erat
ridin
e A
lkal
oid
Vera
trum
sp.
Act
ive
Ball
et a
l., 1
986
Vic
enin
2
Flav
onoi
d Al
loph
ylus
edu
lis
Act
ive
Aris
awa
et a
l., 1
989
Vite
xin
Flav
onoi
d Al
loph
ylus
edu
lis
Allo
phyl
us e
dulis
A
ctiv
e A
ctiv
e O
kam
ot e
t al.,
199
4
Aris
awa
et a
l., 1
989
Vite
xin,
iso
Flav
onoi
d Al
loph
ylus
edu
lis
Act
ive
Aris
awa
et a
l., 1
989
Vite
xin-
2’’-
O-a
lpha
-L-r
ham
nosi
de
Flav
onoi
d Al
loph
ylus
edu
lis
Act
ive
Aris
awa
et a
l., 1
989
Xan
thon
e, 1
,3,5
,6-te
trahy
drox
y X
anth
one
Trip
tero
sper
mum
lanc
eola
tum
A
ctiv
e C
hen
et a
l., 1
992
Xan
thon
e, 1
,3,6
,7-te
trahy
drox
y X
anth
one
Trip
tero
sper
mum
lanc
eola
tum
W
eak
Che
n et
al.,
199
2 X
anth
one,
2,3
,6,7
-tetra
hydr
oxy
Xan
thon
e Tr
ipte
rosp
erm
um la
nceo
latu
m
Wea
k C
hen
et a
l., 1
992
Xan
thon
e, 3
,4,5
,6-te
trahy
drox
y X
anth
one
Trip
tero
sper
mum
lanc
eola
tum
W
eak
Che
n et
al.,
199
2 X
anth
one,
3,4
,6,7
-tetra
hydr
oxy
Xan
thon
e Tr
ipte
rosp
erm
um la
nceo
latu
m
Act
ive
Che
n et
al.,
199
2